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Preface 
 
Protein aggregation is a very fascinating topic concerning the behaviour of proteins 
that can form high molecular structures either spontaneously or artificially, when the 
environmental conditions are modified. The smallest structural unit from which take 
origin an aggregate, called protomer, can assemble in supramolecular structures, 
which are sometimes selected by nature ab initio, or often built up as a response to 
natural or non-natural events. Anyway, in both cases oligomers can follow different 
fates. They can be highly stable, mainly when formed by irreversible phenomena, or 
can represent metastable or even transient events, thus undergoing fast or slow 
dissociation. Covalently linked oligomers are the most stable supra-molecular 
protein structures. The majority of protein oligomers forms through non-covalent 
associations, which can often lead to metastable dimers or oligomers. Their lability 
is essentially related to the nature of the interaction between the subunits, and to the 
extent of interface area. H-bonds are weaker than electrostatic interactions, but they 
can be crucial in anchoring a domain into a specific orientation that can be further 
stabilized by hydrophobic or electrostatic interactions.  
Proteins accomplish several cellular functions required to live and their 
folding/unfolding are constantly checked in cells. Since the biosynthesis on ribosome, 
the protein chains adopt a definite three-dimensional structure known as native 
conformation, thanks to an efficient control-system. When the native state is neither 
achieved either maintained, the proteins can self-assemble forming insoluble 
deposits. The accumulation of these aggregates causes the loss of function of the 
protein and the saturation of the protein control systems (chaperones and proteases); 
this process can causes toxicity and pathogenicity [1-2].  Researchers have been 
aware since the early days of protein studies that, under stress conditions, proteins 
may aggregate, often in an irreversible way. What is new in modern Protein 
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Chemistry is the realization that aggregation is the first etiologic event in an 
increasing number of pathologies and that aggregation often occurs through 
misfolding rather than just unfolding [2,3]. Dramatic examples of pathologies 
associated with misfolding include Alzheimer’s and Parkinson’s diseases, the 
Huntington’s chorea, prion diseases and amyloid lateral sclerosis [4,5]. The common 
feature in all these devasting pathologies is the accumulation of amorphous or more 
often fibrillar protein aggregates, called amyloid fibres, that causes neuronal toxicity 
[6].  The growing interest in protein aggregation is not exclusively restricted to its 
medical implications and to a relatively small number of proteins involved in 
diseases. Oligomeric proteins are prevalent in nature more than we suppose. Several 
proteins have been found to lead to higher oligomers and fibres, suggesting the 
hypothesis that most, if not all, amino acid sequences might be able to misfold in a 
similar ordered way [7]. This evidence places protein misfolding into a much wider 
perspective. It has also been shown more recently that protein aggregation is not 
always toxic but it is an advantageous feature for a number of reasons, including new 
opportunities for functional control, such as allosteric regulation and the 
establishment of higher-order complexity [7]. Oligomerization represents a very 
important phenomenon in the formation of molecular machines, like for motor 
proteins (kinesin, microtubules) that are indispensable to confer cellular integrity, 
intra/intercellular communication and movement. The formation of essential 
“cellular bodies” such as melanosomes, dendritic cell aggresome-like structures, P-
bodies and stress granules depends on protein aggregation [8]. It is also well 
established that some cellular functions involve the formation of amyloid-like 
structures, as occurs for CPEB (cytoplasmic polyadenylation element-binding 
protein) fibres that improve the intraneuronal communications and the consolidation 
of long term memory when they accumulate on the synapsis [9].  The aggregation 
propensity have been exploited by a large number of organism. Even viruses, that 
are not completely “organized” as a cell, are able to infect and destroy the host-cell 
thanks to the capability of the proteins on their envelope to self-assembly [10]. 
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In vivo, protein aggregation occurs in response to a wide range of “stimuli” that could 
be: 
 
- genetic, i.e. a modifications in DNA and or RNA encoding for a monomeric 
precursor; 
- biochemical, i.e. a modifications during the protein anabolism and/or 
catabolism; 
- physicochemical, i.e. changes in pH, temperature, protein concentration, 
ionic strength. 
  
As described, such environmental conditions can have negative or positive effects 
on aggregation propensity and protein functionality. Understanding how proteins 
aggregate has therefore become an important goal of modern Structural Biology.  
Protein aggregates can have very different morphologies which may range from 
amorphous to well ordered fibrillar structures. In the latter case, the aggregated 
species are usually named amyloid fibres from the original idea of Rudolph Virchow 
who, around 1854, thought sugars as important components of the aggregates [11]. 
The current accepted definition is ‘an unbranched protein fibre whose repeating 
substructure consists of β-strands that run perpendicular to the fibre axis, forming a 
cross-β sheet of indefinite length’ [12]. This structure would be a universal fold that 
most if not all proteins may be able to adopt in given conditions [13] It is known that 
the repeating cross-β sheet motif is characterised by an X-ray diffraction pattern with 
a meridional reflection at around 4.7 Å corresponding to the inter-β strand spacing 
and an equatorial reflection at around 6–11 Å corresponding to the distance between 
stacked β-sheets [13,14]. Since these structural features have been observed in 
several aggregates both in vitro than in vivo, the amyloid fold seems to be a very 
stable structure [7]. Another important property of the amyloid deposits is that they 
have inherent birefringence that increases intensely after staining, for instance, with 
the Congo red dye. They are also very resistant to proteolytic degradation. However, 
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there are other mechanisms by which proteins can form ordered aggregates without 
raising the cross-β motif. These include domain-swapping and end-to-end stacking 
[15-17]. 
The medical [18], biological [19] and fundamental [20] interest associated with 
protein aggregation and fibrillogenesis raises the important question of which 
characteristics promote oligomerization and how it is possible to predict and 
modulate this behaviour. A set of principles has been identified. First of all, it is 
assumed that the information is stored linearly along the amino acid sequence [21]. 
Regions with high propensity to aggregate are rich in hydrophobic amino acids and 
poor in charged residues.  π–stacking of aromatic residues has also been implicated 
to play an important role [22,23]. Second, the sequence must have some tendency to 
adopt structural features compatible with the semi-ordered structure observed in the 
repetitive assembly proper of fibres [17,24]. This observation may be easily 
rationalized by considering that essential elements in stabilizing β structures are not 
only the inter-strand hydrogen bonds but also packing of the side chains. Therefore, 
while polyproline is unlikely to form fibres since its conformation is hardly 
compatible with a β-structure, sequences with β-propensity could easily form 
amyloids. Sequences which adopt an α-helical structure in a globular protein can act 
as chameleons and form packed fibrillar β-structures [25-28].  
Finally, the last aspect that seems to be important in fibre formation is that 
aggregation prone regions need to be at least partially if not completely accessible. 
This is easily obtained in peptides and intrinsically unstructured proteins but can be 
more difficult in globular proteins, in which potential β-prone sequences are usually 
well buried in the protein core. Under given conditions it is possible to affect the 
solvent accessibility and the proteins self-assemble.  
Much of what it is known about protein aggregation and misfolding, derives from 
biophysical studies in vitro. Proteins can be grouped into two main families: the 
intrinsically unfolded proteins [29,30], and globular proteins or domains [2]. There 
is a distinct difference between the two families. How the disordered proteins 
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aggregate is quite easy to understand: regions in the linear sequence more 
aggregation prone start the event when their concentration in the cell is above their 
solubility [31,32]. Conversely, it is more difficult to understand how globular 
proteins aggregate. In fact, they generally do not unless exposed to environmental 
perturbations [33]. High temperature [34, 35], high pressure [36,37], low pH [38], 
alcohols [39], chaotropic solvents and sample shaking [40] have widely been used 
for this purpose to study aggregation in vitro. Under these conditions, proteins that 
have evolved to protect their buried hydrophobic core from the solvent accessibility, 
may misfold and aggregate [5,41]. More recently, a subfamily of globular proteins 
was identified whose members have the tendency to aggregate spontaneously 
without the involvment of highly denaturing conditions [42]. To explain this 
behaviour it was hypothesized that local structural fluctuations, rather than global 
changes, could promote conformational transitions which would then initiate 
aggregation. This hypothesis may well explain, for instance, the fibrillation of 
acylphosphatase from S. solfataricus, which retains its global fold and enzymatic 
function under mildly destabilizing conditions [43].   
 
The molecular mechanisms leading to aggregation are still unclear. For this reason, 
small globular proteins may serve as useful models to study aggregation. They are 
simple systems and it is easier to follow the behaviour by changing few parameters 
systematically. Additionally, thanks to their small size, are amenable to 
computational analysis. Finally, it is straightforward to design and produce mutants 
aimed to rigorously investigation on a feature of interest.  
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Route map of this Thesis 
 
In this Thesis, two proteins, RNase A and MNEI have been proposed as models for 
aggregation studies. Although different in structure and in function, they share 
common hallmarks. Both of them are: 
 
a) aggregation prone: their aggregation propensity is well known; 
 
b)  small: their molecular weight, i.e 13.7 KDa for RNase A and 11 KDa for 
MNEI, make them suitable proteins to be studied by several 
physicochemical technics. Additionally it can be easier to produce them as 
recombinant proteins thanks to well optimized procedures;  
 
c) Monomeric: their native monomeric fold make them useful systems to 
monitor the oligomerization pathways starting from a most simple 
protomeric subunit; 
  
Through a multidisciplinary approach, an extensive investigation on the relationship 
between environmental changes and aggregation propensity has been performed. 
Wide attention has been focused on the most common physicochemical agents, such 
as pH, temperature, ionic strength, metalation on stability and aggregation. At the 
same time genetic mutations in “hot- regions” were also investigated.  
The Thesis is divided into three big sections. The Part A, is completely dedicated to 
RNaseA, the natural model. In the Chapter 1 an extensive study on the influence of 
metalation on protein aggregation has been pursued. The following Chapter 2 is 
focused on a RNaseA-Onc mutant designed to investigate the role of hinge loop on 
protein stability and aggregation propensity. 
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The second part of this Thesis, Part B, is ruled by MNEI, the artificial model. In the 
Chapter 3, high attention is given on the characterization of the physicochemical 
properties of MNEI and the propensity to form insoluble, both ordered and 
disordered aggregates, in response to environmental parameters, i.e. pH, temperature 
and ionic strength. In the Chapter 4, the study is aimed to understand the molecular 
basis leading to fibrilization with insight on early steps of unfolding. 
In the third section, Part C, a full description on the production procedures referred 
to the two proteins studied has been reported. 
Each Chapter is a result of an extensive study supported by a wide range of technics 
and by precious collaborations with national and international groups who are greatly 
acknowledged.  
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Part A 
 
 
Natural models 
___________________ 
 
Ribonuclease A 
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State of art 
Bovine pancreatic RNase A (ribonuclease A) is one of the most studied protein in 
structural biology. By lyophilization from 40% acetic acid solutions, it can 
oligomerize in form of dimers, trimers, tetramers, higher order oligomers [1,2]. 
RNase A can also form amyloid fibers [2]. Oligomerization of RNase A also occurs 
in solution at high substrate concentrations or high temperature [3]. The most 
accepted mechanism through RNase A oligomerizes is the so called 3D-domain 
swapping (3D-DS), i.e. the capability to reciprocally exchange protein domains [4]. 
In Fig. 1 a schematic overview is reported. In 3D domain swapping, one domain of 
a monomeric protein is replaced by the same domain from an identical protein chain. 
The result is an intertwined dimer or higher oligomer, with one domain of each 
subunit replaced by the identical domain from another subunit. A protein able to 
swap may interchange a large tertiary globular domain or a small secondary structure 
element as α-helix or a β-sheet [4].  RNase A can exchange both N-domain and the 
C-domain forming two dimeric isomers called as N-dimer and C-dimer, respectively. 
The structure of the more basic or minor trimer has also been solved [1,4]; it is 
formed by three monomers linked to each other by swapping their C-strands, thereby 
forming a circular structure that looks like a propeller. It was called C-trimer. A 
plausible linear model was proposed for the less basic, major trimer. In this linear 
model, two monomers are linked through swapping of their N-termini, and a third 
monomer is bound to one of them by a C-terminal domain swapping. It will be called 
the NC-trimer. According to modelling studies, only plausible models for tetramers 
and higher oligomers are reported. At the moment no X-ray or NMR structures for 
tetramers and oligomers are deposited on databank. In Fig. 2 the cartoon 
representations for N-dimer, C-dimer and C-trimer. All the model structures for 
RNase A oligomers are also reported. Oligomerization through 3D-DS, does not 
affect the enzymatic activity because the interchanging domains reconstitute the 
catalytic site. The conformers are enzymatically active and are endowed with 
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additional biological function such as the cytotoxicity and cytostaticity on cancer 
cells, a property completely absent into the monomeric species [4]. 
 
 
Fig. 1 - 3 D domain swapping scheme 
 
24 
 
 
Fig. 2 RNase A oligomers. Structures and models 
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Bovine pancreatic ribonuclease metalation by Platinum-
based drugs: insight on protein oligomerization 
 
                                 
Abstract 
 
Metalation can influence the oligomerization state of proteins, can alter their 
hydrodynamic properties and/or can cause fine structural variations. Platinum-
complexes are the most successful families of compounds clinically effective and 
commercialized against malignant tumours. In this work, the reaction between 
RNase A and three Pt-complexes clinically effective (cis-platinum, carboplatinum 
and oxaliplatinum) has been analysed. They induce extensive protein aggregation 
leading to the formation of dimers, trimers and higher oligomers that were purified 
at homogeneity. Structural and functional properties of the platinated species, 
together with their spontaneous dissociation and thermally induced denaturation, 
have been characterised. The effects of platination on enzymatic activity and 
biological properties induced by Pt-complexes exposure have been assayed. X-ray 
structures of the Pt-monomeric adducts that RNase A forms provide a rational basis 
to explain the different effects of the three anticancer agents on protein aggregation 
and the relationship between structure and function. In this framework, RNase A 
showed high versatility to study protein-metal interactions that could be crucial for 
the biological (side) effects of several metallodrugs against malignant tumours.  
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1.1 Introduction 
 
Platinum complexes (Fig.1) represent one of the most successful families of 
clinically used anticancer drugs [1]. Cisplatin (cis-Pt Cl2(NH3)2, cis-
diamminedichloroplatinum(II), CDDP) is the best known Pt-based anticancer agent. 
Carboplatin (cis-diammine(cyclobutane-1,1-dicarboxylate-O,O')platinum(II)) and 
oxaliplatin (ethane-dioate(1R,2R)-1,2-cyclohexanediamineplatinum(II)) are two 
CDDP analogues usually employed to treat tumours poorly responsive to cisplatin 
treatments [2].  
 
 
 
 
  
Fig. 1 Platinum complexes: structure of cisplatin, carboplatin and oxaliplatin 
 
 
Pt-based drugs show their pharmacological action through the formation of stable 
DNA adducts [1-3]. The Pt-DNA adducts roll out and bend the DNA duplex, 
favouring the binding by high-mobility group (HMG) proteins that recognize these 
modifications as damage and trigger cell in apoptosis [4]. The formation of DNA 
adducts with CDDP, carboplatin and oxaliplatin has been extensively studied and the 
X-ray structures of these adducts have been solved [3-9]. Nevertheless, nucleobases 
are not the only biological targets of Pt-drugs [3]. Platinum can efficiently interact 
with sulphur atoms of cysteine [7] or methionine residues [8] or even with nitrogen 
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atom of histidine [9,10] or oxygen atoms of aspartic/glutamic side chain residues 
[11]. Actually, while the formation of Pt–DNA adducts has been extensively 
investigated, less attention has been bestowed to the interaction between platinum 
compounds and proteins. After injection into the bloodstream, most of the platinum 
(65 to 98%) is associated with proteins, mainly to serum albumin and hemoglobin. 
Moreover, a significant portion of Pt is bound to ℽ-glutamyl-cysteine-glycine 
(glutathione, GSH) [12] and/or other cysteine-rich proteins [13], like a few small 
proteins of the metallothionein family [14]. Platinum complexes entrance in cells is 
helped by proteins belonging to the so-called “copper trafficking” system [15]. 
Therefore, exploring how platinum-based drugs interact with proteins is worth of 
investigation for a deep understanding of the molecular basis of protein-drug 
recognition, for studying the inherent or acquired pharmacological resistance, for 
evaluating the bio-distribution and the clearance of Pt-based drugs, for the rational 
design of new therapeutic agents more effective against proliferating malignant cells. 
Furthermore, the interaction of these molecules with proteins has drawn increasing 
attention in the last few year, given the role that it plays in defining the toxicity 
profiles of the drugs [16, 17]. Previous studies have shown that Pt metalation can 
alter the hydrodynamic properties in a protein and/or cause fine structural variations 
resulting in oligomerization [18,19]. In order to clarify the relationship between 
platination and aggregation, a comparative study has been pursued by evaluating the 
behaviour of RNase A when incubated in presence of cisplatin, carboplatin and 
oxaliplatin, respectively. RNase A was elected for this study since a) it has been used 
as a model system in many fields of Protein Chemistry, including protein metalation 
[19,20] and protein aggregation [21]; b) it binds cisplatin and details of this binding 
are known [20]; c) it is able to form well characterized dimers and higher oligomers 
[21] which can be used as reference. In particular, RNase A forms a N-terminal 
swapped dimer, hereafter called N-Dimer [22], and a C-terminal swapped dimer, C-
Dimer [23], two trimers characterized by swapping of both C- and N-termini and 
other oligomers [24-26], including tetramers, pentamers and hexamers [27]. Another 
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advantageous aspect is that it is an enzyme, therefore it possible to estimate the effect 
of platination on protein functionality. Interestingly, RNase A aggregates acquire 
selective cytotoxicity towards tumor cells [28]. This work reveals that cisplatin 
(CDDP) deeply induces RNase A oligomerization allowing the isolation of dimer, 
trimer and tetramers. The reaction with carboplatin and oxaliplatin equally produces 
oligomers even if the yield is lower than cisPt reaction. All the platinated species 
were isolated and carefully characterized from a biochemical and physicochemical 
point of view. This work reveals that 24 h incubation at 37 °C of RNase A in the 
presence of an excess of cisplatin, carboplatin and oxaliplatin (1:10 protein to 
metallodrug ratio) induces the formation of platinated monomers (Pt-Mcis ,Pt-Mcarbo 
and Pt-Moxa), dimers (Pt-Dcis ,Pt-Dcarbo and Pt-Doxa), trimers (Pt-Tcis ,Pt-Tcarbo and Pt-
Toxa) and a small amount of higher oligomers. Denaturing and non-denaturing 
polyacrylamide gel electrophoresis and size-exclusion chromatography were used to 
characterize the formation of the oligomers. Circular dichroism and UV-Vis 
spectroscopy were used to investigate their structural stability and catalytic activity. 
In collaboration with the groups of Proffs. M.Donadelli and G.Gotte from the 
University of Verona, a functional characterisation  on cytotoxic and cytostatic 
properties has been pursued.  
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1.2 Materials and methods  
 
1.2.1 Production and purification of platinated species 
 
Cisplatin and RNase A (type XII-A) were purchased from Sigma- Aldrich. RNase A 
was further purified as described in [29]. Carboplatin and oxaliplatin were purchased 
from Santa Cruz Biotechnology. Preliminary incubations for analytical purposes 
were pursued by incubating RNase A with cisplatin. Platinated species were obtained 
by incubating RNase A at a protein: metallodrug molar ratio of 1:10. RNase A was 
incubated at a concentration of 5 mg × ml-1 in 0.20 M sodium phosphate buffer pH 
6.7 at 37° C for 24 hours with mild shaking. The platinated species were purified by 
size exclusion chromatography. The reaction mixture was loaded on a Sephadex G75 
column (1.5 × 72 cm) previously equilibrated in 0.20 M sodium phosphate buffer pH 
6.7, at a flow rate of 0.15 ml×min-1. Concentration of all platinated species was 
spectrophotometrically measured at 280 nm, using the extinction coefficient of 
RNase A (ɛ 1% at 280 nm= 0.695). Sample homogeneity for all the platinated species 
was assessed by polyacrylamide gel electrophoresis under denaturing (SDS-PAGE 
15%) [30] and non-denaturing conditions (12% native PAGE) [31].  
 
1.2.2 Circular dichroism spectroscopy 
 
The gel-filtered Pt-species were analyzed with far-UV CD spectroscopy, at the 
concentration of 0.1 mg × ml−1 in 0.20 M sodium phosphate buffer, pH 6.7.  Circular 
dichroism (CD) experiments were performed on a Jasco J-810 spectropolarimeter 
(JASCO Corp., Milan, Italy) at 25 °C. Quartz cells with path length of 0.1 cm were 
used in the far-UV region from 200 to 250 nm. Each spectrum was obtained 
averaging three scans, subtracting contributions from the corresponding reference 
and converting the signal to mean residue ellipticity in units of deg × cm2 × dmol−1. 
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Other experimental settings were: 20 nm × min−1 scan speed, 2.0 nm band width, 0.2 
nm resolution, 50 mdeg sensitivity, and 4 s response. Thermal unfolding profiles 
were obtained by monitoring the CD signal at 222 nm as function of temperature, in 
the range 20–100 °C, with a heating rate of 1.0 °C × min−1. 
 
1.2.3 Enzymatic activity 
 
Ribonuclease activity of the purified RNase A platinated species was measured by 
using the spectrophotometric Kunitz method, i.e. monitoring the cleavage of yeast 
RNA via UV-Vis spectroscopy [32] at 25 °C in 0.050 M sodium acetate pH 5.0, 
using 0.5 mg × ml-1 of RNA and an enzyme concentration of 0.5 μg × ml-1. The 
activity of the platinated proteins was also compared to that obtained under the same 
experimental conditions for RNase A. 
 
1.2.4 Dissociation experiments 
 
The stability of the gel filtered species was assessed by incubating at 4 and 37 °C 
aliquots of the fraction corresponding to the maximum of each form, without any 
further modification, in 0.20 M sodium phosphate buffer, pH 6.7, for time intervals 
settled between 1 and 35 days. The dissociation kinetics was monitored by cathodic 
polyacrylamide gel electrophoresis under non-denaturing conditions.  
 
1.2.5 Crystallization and X-ray diffraction data collection 
 
To obtain crystals, all the purified species were treated at 25 °C by Prof. A . Merlino 
and coworkers using the hanging drop vapor diffusion method, protein concentration 
of 15 mg × ml−1 and precipitant solution containing 30% ammonium sulfate and 0.30 
M sodium chloride. Only crystals of purified cisplatin and carboplatin monomers 
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were obtained, within 7 days. Complete data sets for Pt-monomers wer collected at 
100 K at the CNR Institute of Biostructures and Bioimages, Naples, Italy, using a 
Saturn 944 CCD detector equipped with CuKα X-ray radiation from a Rigaku 
Micromax 007 HF generator. The crystals diffract at 1.95 Ǻ resolution. Coordinates 
and structure factors on cisplatin-monomer and carboplatin-monomer were 
deposited in the Protein Data Bank under the accession codes 4RTE and 5NA9, 
respectively.  
 
 
1.2.6 Cell lines and cellular proliferation assay 
 
Cytotoxic effect of each platinated species was assayed on tumoral cell lines Panc1 
(deriving from pancreatic adenocarcinoma), A549 and SKBR3 (deriving from breast 
cancer). Cellular proliferation assays were performed by the group of Prof. M. 
Donadelli. Cells were seeded in 96-well plates (5x103 cells/well) at 37 °C with 5% 
CO2 and 24 h later were treated with the various compounds and further incubated 
for 96 h. At the end of the treatments cells were stained with a Crystal Violet solution 
(Sigma, Milan, Italy) to determine cell growth photometrically at 595 nm. ANOVA 
(post hoc Bonferroni) analysis was performed by GraphPad Prism 5 software. P 
value < 0.05 was indicated as statistically significant. Values are the means of three 
independent experiments (± SD). 
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1.3 Results and Discussion 
 
1.3.1 Platinum complexes influence the oligomerization state of  
RNase A 
 
Previous studies have shown that Pt metalation of proteins can induce the formation 
of protein oligomers and/or cause subtle structural variations [18]. The first aim of 
this work was to monitor the formation of possible aggregates produced by 
incubation of RNase A with cisplatin, carboplatin and oxaliplatin. Preliminary 
studies have been pursued using cisplatin (CDDP), the simplest Pt-compound. 
RNase A was incubated at a concentration of 5 mg×ml-1 for 24 hours at 37 °C in the 
presence of cisplatin in a 1:10 protein:cisplatin molar ratio in 0.20 M sodium 
phosphate buffer, pH 6.7.. Additionally, another aliquot of RNase A was dissolved 
at a concentration of 5 mg×ml-1 in 40% V/V acetic acid/water solution, incubated for 
1 hour at 37° C, lyophilized and then dissolved in 0.20 M sodium phosphate buffer 
according to the protocol described by Crestfield [34]. For further comparison, a 
third aliquot of RNase A was also incubated without cisplatin in sodium phosphate 
buffer. After incubation, the oligomerization was evaluated by cathodic PAGE under 
non-denaturing conditions. Two different amounts of protein were loaded on 
polyacrylamide gel, corresponding to 5 and 10 µg, respectively. The resulting 
electrophoretic patterns are shown in Fig. 2-A. Cisplatin incubation results in an 
appreciable oligomerization. Moreover, cisplatin induces structural modifications 
also on the native monomeric RNase A, influencing its electrophoretic mobility:  as 
showed in Fig.2, the latter band in lanes 1-2 migrates more than the latter band in 
lanes 3-4 and 5, corresponding to the monomeric RNase A present in solution upon 
AcOH lyophilisation and the native RNase in pure buffer, respectively. In order to 
investigate the effects on RNase A oligomerization of two other Pt-drugs, i.e. 
carboplatin and oxaliplatin, the protein was incubated in the same experimental 
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conditions described for cisplatin. In the same way, a small amount of untreated 
RNase A was loaded on the native gel. Fig. 2-B reports that also carboplatin (lane 2) 
and oxaliplatin (lane 3) influence the oligomerization state of RNase A.  
In all the cases analysed, the platinum complexes influence the oligomerization state 
of RNase A.  
 
 A B  
 
Fig. 2 Oligomerization patterns of RNase A: cathodic gel electrophoresis under native conditions 
(12% PAGE). A: incubation with cisplatin (lanes 1 and 2), lyophilization upon incubation in 40% 
acetic acid  (lanes 3 and 4), and native RNase A incubated in 0.20 M sodium phosphate buffer, pH 
6.7 (lane 5). B: incubation with carboplatin (lane 2), incubation with oxaliplatin (lane 3). RNase A 
dissolved in water is also reported as reference (lane 1). 
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1.3.2 Production and purification of platinated oligomers 
 
Since analytical preparations show that cisplatin, carboplatin and oxaliplatin 
influence the oligomerization state of RNase A, a new set of incubations were putted 
on. Similar amounts of RNase A were incubated as described in “Materials and 
Methods” section. For each preparation, 15 mg of protein were dissolved in 3 ml of 
0.20 M sodium phosphate buffer, pH 6.7. To each protein solution were added the 
following amounts of metallodrug: 3.3 mg of cisplatin, 4.1 mg of carboplatin and 4.3 
mg of oxaliplatin to obtain the RNase A: Pt-drug molar ratio of 1:10.  Each mixture 
was incubated at 37 °C for 24 hours under gentle shacking. Since the electrophoretic 
patterns (Fig. 2,panels A-B) suggest the presence of oligomers with different 
molecular weights, the platinated species were purified by size-exclusion 
chromatography. Thus, the protein-drug solutions were loaded on a Sephadex G75 
(1.5 ×72 cm) column previously equilibrated in 0.20 M sodium phosphate buffer, pH 
6.7. The elution was carried on at a flow rate of 0.15 ml×min-1. Fig. 3 reports the 
corresponding gel-filtration profiles obtained for the three metallodrugs. In 
accordance with the cathodic PAGE, high oligomerization occurs. A comparative 
analysis of the peak area suggests that the oligomerization yield increases in the 
direction oxaliplatin < carboplatin < CDDP. Cisplatin is the most effective giving 
rise to the formation of high amount of dimer, trimer, tetramer and traces of 
multimers of high molecular weight. Peak integration reveals that about 60% of the 
protein is eluted as monomer (indicated as M), whilst approximately 25 % is eluted 
as dimer (indicated as D), 8 % as trimer (indicated as T) and 4% as tetramer 
(indicated as Tt). A small amount, roughly equivalent to the remaining 3% of the 
total, corresponds to higher size aggregates (indicated as O). On the other hand, the 
profiles obtained upon incubation with carboplatin and oxaliplatin reveal that the 
amount of dimer, trimer and other oligomers decreases; in more detail, oxaliplatin 
incubation results in dimerization lower than carboplatin.  
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Fig. 3 Chromatographic profiles: Gel-filtration pattern on a Sephadex G75 (1.5 × 72 cm) column 
after 24 h of incubation at 37 °C in the presence of cisplatin (red line), carboplatin (blue line) and 
oxaliplatin (green line) in 1:10 protein:metallodrug molar ratio in x nM sodium phosphate buffer, pH 
6.7 . The peaks corresponding to metalated monomer (M), metalated dimer (D), metalated trimer 
(T),metalated tetramer (Tt) and metalated oligomers (O) are highlighted. A zoomed section on dimer-
trimer and higher oligomers is also reported. 
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1.3.3 Biochemical characterization: Pt-species are interestingly SDS 
resistant and strongly stable over time 
 
All the platinated species purified were subjected to PAGE under native and 
denaturing conditions. The gel filtered fractions migrate as a single spot in non-
denaturing conditions, suggesting the presence of a single conformer in each fraction 
(Fig 4, panels B-C-D). Moreover, RNase A incubated in phosphate buffer was also 
subjected to native PAGE as control, revealing that no oligomerization occurs if 
platinum is not present. For a further comparison, an aliquot of RNase A dissolved 
after lyophilization from 40% acetic acid was also loaded (panel A). Interesting 
differences among the oligomerization observed upon lyophilization from acetic acid 
solution and Pt-metalation are more evident on the denaturing SDS-PAGE (Fig.5, 
panels B-C-D). In fact, while oligomers formed by acetic acid lyophilisation 
dissociate thus migrating as a single spot corresponding to the monomeric protein 
(panel A), platinated species show a peculiar SDS resistance. This suggests that 
platinum allows interactions between subunits that are different from those occurring 
in the well-known swapped dimers and oligomers of RNase A. Besides the chemical 
resistance to denaturing SDS treatment, the resistance at two conditions of 
temperature was also monitored over time. Each Pt-species was incubated at the 
typical storage temperature of 4 °C and at the physiological temperature of 37 °C. 
The stability of the different aggregates was monitored until 35 days. Samples were 
analysed by native PAGE. The electrophoretic patterns after prolonged time is 
reported in Fig. 6. Both carboplatin and oxaliplatin oligomers show a weak 
dissociation at 4 °C and 37 °C. Differently, cisplatin species are resistant at least up 
to 35 days at 4 °C while a slow but constant dissociation occurs at 37 °C. Anyway, 
all the platinated species are more stable than the well-known swapped dimers in all 
the experimental conditions investigated. 
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A  B     
 
 
    C       D     
 
Fig. 4 Aggregation profiles: Gel-electrophoresis under native conditions (cathodic PAGE 12%) of 
purified platinated oligomers obtained incubating RNase A in the presence of cisplatin (B),  
carboplatin (C) and oxaliplatin (D). M: monomer, D: dimer; T: trimer; Tt: tetramer. RNase A 
dissolved in water and in phosphate buffer are also loaded as references togheter with a RNase A 
sample incubated in 40% acetic acid and liophylized. 
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             A      B  
             C            D    
 
Fig. 5 Aggregation profiles: Gel-electrophoresis under denaturing conditions (SDS-PAGE 15%) of 
of purified platinated oligomers obtained incubating RNase A in the presence of cisplatin (B),  
carboplatin (C) and oxaliplatin (D). M: monomer, D: dimer; T: trimer; Tt: tetramer. RNase A 
dissolved in water and in phosphate buffer are also loaded as references togheter with a RNase A 
sample incubated in 40% acetic acid and liophylized. 
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A  
 
                               B  
                              C  
 
 
Fig. 6 Dissociation profiles. Gel-electrophoresis under native conditions (cathodic PAGE 12%) of 
purified platinated oligomers obtained by incubating RNase A in the presence of cisplatin (A), 
carboplatin ( B) and oxaliplatin (C) upon 35 days of storage at 4 °C and 37 °C. M: monomer, D: 
dimer; T: trimer; Tt: tetramer. 
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1.3.4 Physicochemical characterization: Pt-species are folded and 
moderately thermostable 
 
In order to characterize from a structural point of view the effect of cisplatin, 
carboplatin and oxaliplatin binding to RNase A in solution, the spectroscopic 
properties of the platinated monomeric, dimeric and trimeric species were studied by 
CD, which is a sensitive technique to monitor the secondary structure of proteins 
[34]. Far-UV CD spectra are shown in Fig. 7 (panel A, cisplatin; panel B, carboplatin; 
panel C, oxaliplatin). The spectra are almost indistinguishable from each other, 
revealing that all the platinated species, i.e. monomeric and oligomeric forms,  are 
well-folded and suggest that they are assemblies of native RNase A monomers. This 
behavior demonstrates that drug complexation causes no denaturation of RNase A, 
supporting the idea that the formation of Pt adducts does not induce major 
conformational changes of the native protein structure. 
With the aim to characterize the thermal stability of the platinated monomer, dimer 
and trimer, the CD signal at 222 nm was recorded as a function of temperature, in 
0.20 M phosphate buffer at pH 6.7. These conditions are very similar to those used 
to characterize the stability of N-Dimer and C-Dimer, i.e. the N-terminal and C-
terminal swapped dimers of RNase A (0.10 M phosphate buffer pH 6.8) [35].  The 
thermal denaturation profiles are reported in Fig. 8 (panel A, cisplatin; panel B, 
carboplatin; panel C, oxaliplatin). The curves of the Pt-species show a sharp 
sigmoidal transition that can be described using a two-state model.  All the Tm alues 
obtained are summarized in Table 1. Cisplatinated species have the same Tm of the 
native RNase A. Carboplatin species are moderately thermostable but less than the 
native monomeric RNase A. Finally, oxaliplatin forms show Tm values highest than  
native RNase A and  other platinated species. Interestingly, all the platinated dimers 
are more stable than the well known swapped dimers [35]. 
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Fig. 7 Spectroscopic analysis on platinated species. CD spectra (25 °C) at a protein concentration 
of 0.1 mg×ml -1in 0.20 M sodium phosphate buffer, pH 6.7. A: cisplatin; B: carboplatin; C: oxaliplatin. 
M: monomer (red) ;D:dimer (blu); T:trimer (magenta). The CD spectra recorded for RNase A (black) 
is also reported in panel A as reference. 
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Fig 8 Thermal denaturation analysis on platinated species. Thermal unfolding curves at 222 nm 
measured at a protein concentration of 0.1 mg×mL-1 in 0.20 M sodium phosphate buffer pH 6.7. A: 
cisplatin; B: carboplatin; C: oxaliplatin. M: monomer (red) ;D:dimer (blu); T:trimer (magenta). The 
CD spectra recorded for RNase A (black) is also reported in panel A as reference. 
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Protein Tm °C) 
RNase A 66 ± 1 
Pt-MCDDP 66 ± 1 
Pt-DCDDP 66 ± 1 
Pt-TCDDP 65 ± 1 
Pt-Mcarbo 63 ± 1 
Pt-Dcarbo 62 ± 1 
Pt-Tcarbo 64 ± 1 
Pt-Moxa 67 ± 1 
Pt-Doxa 67 ± 1 
Pt-Toxa 69 ± 1 
C-terminal swapped dimer of 
RNase A* 
66.4 
N-terminal swapped dimer of 
RNase A** 
50.0 
66.4 
 
Tab. 1 Thermal unfolding parameters. Comparison between the denaturation temperatures of 
platinated oligomers of RNase A obtained upon incubation with cisplatin, carboplatin and oxaliplatin, 
with those found for RNase A, N-terminal and C-terminal swapped dimers of RNase A.  
  
*Parameters of the temperature-induced denaturation of N-terminal and C-terminal swapped 
dimer of RNase A have been obtained in 0.1 M phosphate buffer at pH 6.6, through DSC 
measurement [35].  
**N-terminal swapped dimer of RNase A unfolds according to a three-state denaturation 
mechanism, which includes the formation of an intermediate; for this reason, in this case, 
two T1/2 temperatures are reported [35].  
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1.3.5 Functional characterization: enzymatic activity 
 
In order to estimate if platination could affect the protein functionality, the enzymatic 
activity for all platinated species was assayed. As described in “Materials and 
Methods” section, the ribonucleolytic action of platinated forms was measured by 
monitoring hydrolysis of yeast RNA at pH 5.0 using the Kunitz method [32]. The 
absorbance variations at 300 nm ( ΔA 300nm )  as a function of time, upon addition of 
the same amount of RNase A or platinated species dissolved at a concentration of 
0.5 μg × ml-1 to 1 ml of a 0.5 mg × ml-1 yeast RNA solution were monitored by UV-
spectroscopy.  Fig. 9 reports the enzymatic activity profiles recorded for each species, 
i.e. cisplatin (Panel A), carboplatin (Panel B) and oxaliplatin (Panel C). The 
platinated species show different enzymatic activity. Indeed, CDDP-species retain a 
significant, although reduced, enzymatic activity (Fig.9- panel A). CarboPt species 
show catalytic properties comparable to native RNase (Fig.9-panel B). Finally, 
oxaliPt adducts show a behaviour similar to the one observed for CDDP-forms 
(Fig.9-panel C). The enzymatic activity analysed for each form can be summarized 
according to the scheme: carboplatin activity > oxaliplatin activity  > cisplatin activity . In 
Fig. 10 an overview of the behaviours observed for Pt-dimers (Panel A) and Pt-
trimers (Panel B) is reported. As clearly indicated in Fig.10, all the carboplatinated 
purified species (lane magenta) preserve an enzymatic action significantly higher 
than the other forms obtained from the incubation with cisplatin or oxaliplatin. 
Interestingly, the aggregation due to the exposure to carboplatin does not affect the 
hydrolytic properties, differently from what observed in the two other cases, where 
the functionality significantly decrease in proportion to the molecular weight. 
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Fig. 9 Enzymatic activity monitored by the Kunitz assay . Cisplatin (A), Carboplatin (B) 
oxaliplatin (C). RNA hydrolysis was monitored at 300 at 25 °C in 0.050 M sodium acetate buffer pH 
5 at a protein concentration of 0.5 µg×ml-1. A: cisplatin; B: carboplatin; C: oxaliplatin. M: monomer 
(red) ;D:dimer (blu); T:trimer (magenta). The ribonucleolytic activity recorded for RNase A (black) 
is also reported as reference. 
A 
B 
C 
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Fig. 10 Enzymatic activity monitored by the Kunitz assay. Pt-Dimers (A); Pt-Trimers (C). RNA 
hydrolysis at 600 at 25 °C in 0.050 M sodium acetate buffer pH 5 at a protein concentration of 0.5 
µg×ml-1. CDDP: red; oxaliplatin: blu; carboplatin: magenta. The ribonucleolytic activity recorded for 
the native monomeric RNase A  (black) is also reported as reference 
A 
B 
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1.3.6 Functional characterization: cytotoxic action 
 
Given the variety of effects observed on the enzymatic activity upon reaction with 
the different Pt complexes, the cytotoxic action has been also assayed  in a panel of 
cancer cell lines from a series of solid tumors, as A549 (from lung carcinoma), Panc1 
(from pancreatic adenocarcinoma) and SKBR3 (from breast cancer). The present 
study has been performed by the group of Proffs. G. Gotte and M. Donadelli of the 
University of Verona. Although the cell lines used are well known to be responsive 
to Pt-based drugs (cisplatin, carboplatin and oxaliplatin), cell proliferation was not 
affected by any of the platinated RNase A species. In particular, monomer, dimer, 
trimer and oligomers of RNase A did not significantly affect proliferation of A549, 
Panc1, and SKBR3 cells also when conjugated with cisplatin drug (Fig. 11, panel A). 
An equivalent result has been obtained with monomer, dimer, and oligomers of 
RNase A conjugated with carboplatin or oxaliplatin in A549 cells (Fig. 11, panel B). 
Altogether, these data indicate that RNase A species conjugated with Pt-based drugs 
did not acquire any cytotoxic property in cancer cells as compared to RNase A 
species alone but, instead, metalation significantly reduces the cytotoxicity of the 
drugs against the analyzed cell lines.  
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Fig. 11 Effect of platinated RNase A species on the proliferation of cancer cell lines. (A) Panc1, 
SKBR3 and A549 cells were seeded in 96-well plates, incubated overnight, and treated for 96 hours 
with 100 µg mL-1 of RNase A monomer or oligomers (a pool of dimers, trimers and larger oligomers) 
before or after incubation with CDDP. (B) A549 cells were seeded in 96-well plates, incubated 
overnight, and treated for 96 hours with 100 µg/ml of RNase A monomer or oligomers (a pool of 
dimers, trimers and larger oligomers) before or after incubation with carboplatin or oxaliplatin. Cell 
proliferation was determined using the Crystal Violet colorimetric assay. Values are means (±SD) of 
three independent experiments, each performed in triplicate 
A 
B 
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1.3.7 Structural characterization: crystallographic structures of 
cisPt-monomer and carbo-Pt monomer 
 
In order to clarify the effect of platinum-based drug on stability and oligomerization, 
a fine structural analysis has been performed by Prof. Merlino and coworkers. All 
the purified Pt-species were accurately treated to obtain X-ray diffracting crystals as 
described in “Materials and Methods” section. Only cisplatined monomer and 
carboplatin monomer crystalized. Interesting structural hints come from the crystal 
analysis. The X-ray structures of the adducts formed by soaking  native RNase A 
crystals with a stabilizing solution containing an excess of oxaliplatin were already 
reported [20]. Oxaliplatin adducts with RNase A crystals, showed that the platinum 
centre binds the side chain of Asp14 and Asp101, beyond the side chain of His119. 
The Pt-binding sites for Pt-M CDDP and Pt-M carbo are highlighted in Fig. 12. 
Crystals of purified Pt-M CDDP, deposited under the PDB code 4 RTE, diffracted X-
ray at 1.95 Å resolution. Inspection of the electron density maps revealed that, 
although with partial occupancy, three distinct binding sites of cisplatin fragment can 
be identified on the RNase A surface. The r.m.s.d. value of 0.30 Å for Cα atoms 
between the model of Pt-M and that of the native enzyme derived from isomorphous 
crystals indicates that negligible perturbations occur in the structure upon cisplatin 
binding. The main binding site of the drug is located in proximity of Met29 side 
chain, with the Pt center (occupancy factor= 0.60) bound to the side-chain SD atom 
retaining, as expected, two ammonia molecules and a chloride ion as ligands. Since 
in this region residual electron density map is observed, a second Pt atom has been 
added to the model (occupancy factor = 0.40), which is indicative of an alternative 
conformation of the cisplatin fragment. The other two (minor) drug-binding sites (Pt 
occupancy factor between 0.2 and 0.4) are located close to His105 and His119 side 
chains. In both the cases, the Pt center is bound to an N atom of the imidazole ring 
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of His after releasing a chloride ion. Since His119 is involved in the catalytic site of 
RNases, these data can partly explain the results of the decreased enzymatic activity.  
Crystals of purified carbo-Pt monomer diffract X-ray at 2.07 Å resolution. The X-
ray structure is registered under the PDB code 5NA9. The crystallographic structure 
is very similar to that of the ligand-free protein, and to those of Pt-M CDDP  and RNase 
A-carboplatin adduct obtained by soaking procedure, deposited in the PDB under the 
accession code 4S0Q: Cα root mean square deviations from the corresponding atoms 
of the two chains of the RNase A-carboplatin structure obtained by soaking 
procedure are both equal to 0.49 Å. As observed in RNase A-carboplatin, carboPt-
monomer showed a single Pt binding site, close to Met29 side chain.  
The low content of Pt bound to the protein and the finding that carboplatin fragments 
does not bind protein active site residues, contrarily to what was observed for 
cisplatin and oxaliplatin , can well explain both the the higher catalytic activity 
exhibited by Pt-Mcarbo when compared with its analogues. Furthermore, the finding 
that Pt-Mcarbo has just one Pt binding site allows to conclude that Met29 is very likely 
involved in the process that leads to the formation of platinated RNase A dimers and 
higher oligomers.  
    
Fig. 12 Pt-binding sites on platinated monomer. Cartoon representation.  
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1.4 Conclusions and ongoing works 
 
The formation of protein aggregates is a topic of great interest in molecular evolution, 
medicine and biotechnology. The oligomerization state of a protein can be deeply 
influenced by several environmental conditions. Metalation is one of the factors that 
can affect protein stability and aggregation propensity. Recently high attention is 
focused on the effects of metal-based drugs on protein-protein interaction. In fact, 
even if the pharmacological effects are mainly related to nucleobases-metals 
interactions, the direct effects of metalation on cellular uptake, biodistribution and 
pharmacological clearance of these drugs are not completely clear. In this scenario, 
this work investigates the relationship between Pt-metalation and protein 
aggregation. Platinum-based drugs are the most effective chemotherapycs and show 
different pharmacological response on the basis of their chemical composition. 
RNase A turned out as a helpful model to study the protein oligomerization 
propensity induced by the exposure to three common Pt-based drugs: cisplatin, 
carboplatin and oxaliplatin. This study reveals that all the metallodrugs significantly 
influence the RNase A aggregation propensity. In more details, the reaction with 
cisplatin gives rise to a wide range of Pt-aggregates triggering  the formation of one 
dimer, one trimer, one tetramer and higher oligomers. Carboplatin and oxaliplatin 
are also able of forming RNase A platinated oligomers even if the final amount of 
dimers and higher oligomers is lower in comparison with the pattern obtained with 
cisplatin. All the oligomers were purified and deeply characterized. These adducts 
share similar folding and thermostability, and display SDS resistance and quite 
prolonged survival in solution. Among the three drugs, CDDP, the most potent 
oligomerization agent, is also the most effective in inhibiting the ribonucleolytic 
activity of the protein. Oxaliplatin forms the lower amount of oligomeric adducts and 
shows functional properties similar to the CDDP-adducts. On the other hand 
oligomers obtained in the presence of carboplatin are the most active as enzymes. X-
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ray structures of the monomeric adducts allowed to identify different binding 
features of the three Pt compounds that account for their different influence on the 
catalytic activity and on the aggregation features of the protein complexes. In 
particular, the different influence of the Pt-based drugs on the catalytic activity can 
be explained by looking at active site accessibility upon metal binding: carboplatin 
adducts retain the full catalytic activity because their active site residues are not 
involved in metal binding and thus the substrate binding is not affected, at variance 
with what is observed in the adducts of the two other metallodrugs. The aggregation 
propensity can be explained by looking at the number of metal binding sites on the 
protein surface and at the chemical features of the Pt coordination sphere. Pt-Mcarbo 
leads to the formation of a lower amount of oligomers when compared to CDDP, 
since it possesses a single Pt binding site, whereas Pt-MCDDP can bind three CDDP 
fragments, two of them involving residues located on the protein surface. The lowest 
aggregation propensity of the oxaliplatin adduct can be explained considering that 
the 1,2-diaminocyclohexane (DACH) ligand is not easily released from the Pt centre, 
even upon the binding to the protein, hampering the assembly of two RNase A chains.  
The evaluation of the effects of the presence of these adducts in cancer cell 
proliferation sensitive to the treatment with pancreatic-like RNases [36,37] reveals 
that the platinated RNase A oligomers are not cytotoxic. Thus, although protein 
oligomerization generally increases RNase A cytotoxicity [38], platinated oligomers 
of RNase A do not display any additional feature that could improve a possible 
cytotoxic activity associated with the formation of oligomers, but on the contrary 
they deprive the cytotoxic properties of cisplatin, carboplatin, and oxaliplatin. 
Altogether, these data indicate that possible aggregation processes of proteins by 
anticancer Pt-based drugs could represent a collateral drawback, which on one hand 
can affect the functional state of several protein targets triggering their aggregation, 
whereas on the other hand the efficacy of Pt-based drug treatment can be drastically 
reduced.  
 
54 
 
1.5 References 
 
[1] Comess KM and Lippard SJ. (1993) Molecular Aspects of Platinum-DNA 
Interactions, Molecular Aspects of Anticancer Drug-DNA Interactions. Macmillan, 
London  
[2] Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K and Fojo T. (1996) 
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-
resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer 
Drug Screen panel, Biochemical pharmacology. 52, 1855-1865. 
[3] Takahara PM, Rosenzweig AC, Frederick C A and Lippard SJ. (1995) Crystal 
structure of double-stranded DNA containing the major adduct of the anticancer drug 
cisplatin, Nature. 377, 649-52. 
[4] Jamieson ER, Jacobson MP, Barnes C M, Chow CS and Lippard SJ. (1999) 
Structural and kinetic studies of a cisplatin-modified DNA icosamer binding to 
HMG1 domain B. J Biol Chem. 274, 12346-54 
[5] Jamieson ER and Lippard SJ. (1999) Structure, recognition, and processing of 
cisplatin–DNA adducts. Chem Rev. 99, 2467–2498. 
[6] Arnesano F, Banci L, Bertini I, Felli IC, Losacco M and Natile G. (2011) Probing 
the interaction of cisplatin with the human copper chaperone Atox1 by solution and 
in-cell NMR spectroscopy. Journal of the American Chemical Society. 133, 18361-
9 
[7] Messori L. and Merlino A. (2014) Cisplatin binding to proteins: molecular 
structure of the ribonuclease A adduct.  Inorganic chemistry. 53, 3929-31 
55 
 
[8] Casini A, Mastrobuoni G, Temperini C, Gabbiani C, Francese S, Moneti G, 
Supuran C. T, Scozzafava A and  Messori L. (2007) ESI mass spectrometry and X-
ray diffraction studies of adducts between anticancer platinum drugs and hen egg 
white lysozyme, Chemical communications, 156-158 
[9] Tanley SW, Schreurs AM, Kroon-Batenburg LM, Meredith J, Prendergast R, 
Walsh D, Bryant P, Levy C and Helliwell J.R. (2012) Structural studies of the effect 
that dimethyl sulfoxide (DMSO) has on cisplatin and carboplatin binding to histidine 
in a protein, Acta crystallographica Section D, Biological crystallography. 68, 601-
12 
[10] Mizumura Y, Matsumura Y, Hamaguchi T, Nishiyama N, Kataoka K, 
Kawaguchi T, Hrushesky WJ, Moriyasu F and  Kakizoe T. (2001) Cisplatin-
incorporated polymeric micelles eliminate nephrotoxicity, while maintaining 
antitumor activity Jpn J Cancer Res. 92, 328-36 
[12] Messori, L. & Merlino, A. (2014) Cisplatin binding to proteins: molecular 
structure of the ribonuclease A adduct, Inorganic chemistry. 53, 3929-31 
[13] A. Casini, G. Mastrobuoni, C. Temperini, C. Gabbiani, S. Francese, G. Moneti, 
C.T. Supuran, A. Scozzafava, L. Messori, Chem. Commun. (2007) 156–158. 
[14] Tanley SW, Schreurs AM, Kroon-Batenburg LM, Meredith J, Prendergast R, 
Walsh D, Bryant P, Levy C and Helliwell JR (2012) Acta Crystallogr. D68 601–612. 
[15] Kartalou M and  Essigmann JM. (2001) Recognition of cisplatin adducts by 
cellular proteins, Mutat Res. 478, 1-21 
[16] Messori L and Merlino A. (2016) Cisplatin binding to proteins: A structural 
perspective, Coordin Chem Rev. 315, 67-89. 
56 
 
[17] Pinato O, Musetti C and Sissi C. (2014) Pt-based drugs: the spotlight will be on 
proteins, Metallomics : integrated biometal science. 6, 380-395. 
[18] Li HL, Wells S A, Jimenez-Roldan J E, Romer R A, Zhao Y, Sadler PJ and 
O'Connor PB. (2012) Protein flexibility is key to cisplatin crosslinking in calmodulin, 
Protein Sci. 21, 1269-1279 
[19] Picone D, Donnarumma F, Ferraro G, Russo Krauss I, Fagagnini A, Gotte G 
and Merlino A. (2015) Platinated oligomers of bovine pancreatic ribonuclease: 
Structure and stability, Journal of inorganic biochemistry. 146, 37-43 
[20] Messori L, Marzo T and Merlino A. (2015) Interactions of Carboplatin and 
Oxaliplatin with Proteins: Insights from X-ray structures and mass spectrometry 
studies of their Ribonuclease A adducts, Journal of inorganic biochemistry. 153, 
136-142. 
[21] Gotte G, Laurents DV, Merlino A, Picone D, Spadaccini R. FEBS 
Lett2013)15;587(22):3601-8 
[22] Liu YS, Hart PJ, Schlunegger M P and Eisenberg D. (1998) The crystal structure 
of a 3D domain-swapped dimer of RNase A at a 2.1-angstrom resolution, P Natl 
Acad Sci USA. 95, 3437-3442. 
[23] Liu YS, Gotte G, Libonati M and Eisenberg D. (2001) A domain-swapped 
RNase A dimer with implications for amyloid formation, Nat Struct Biol. 8, 211-214. 
[24] Liu YS, Gotte G, Libonati M and Eisenberg D. (2002) Structures of the two 3D 
domain-swapped RNase A trimers, Protein Sci. 11, 371-380. 
[25] Gotte G and Libonati M. (1998) Two different forms of aggregated dimers of 
ribonuclease A, Bba-Protein Struct M. 1386, 106-112. 
57 
 
[26] Gotte G and Libonati M. (2008) Oligomerization of ribonuclease A under 
reducing conditions, Bba-Proteins Proteom. 1784, 638-650. 
[27] Gotte G and Libonati M. (2004) Oligomerization of ribonuclease A - Two novel 
three-dimensional domain-swapped tetramers, J Biol Chem. 279, 36670-36679. 
[28] Matousek J, Gotte G, Pouckova P, Soucek J, Slavik T, Vottariello F and Libonati 
M. (2003) Antitumor activity and other biological actions of oligomers of 
ribonuclease A, J Biol Chem. 278, 23817-22. 
[29] Fagagnini A, Montioli R, Caloiu A, Ribó M, Laurents DV and Gotte G. (2017) 
Extensive deamidation of RNase A inhibits its oligomerization through 3D domain 
swapping. Biochim Biophys Acta. 1865(1):76-87 
[30] Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4.  Nature 227(5259), 680–685 
[31] Sica F, Pica A, Merlino A, Russo Krauss I, Ercole C and Picone D. (2013) The 
multiple forms of bovine seminal ribonuclease: Structure and stability of a C-
terminal swapped dimer. Febs Lett. 587, 3755-3762. 
[32] Kunitz, M. (1946) A spectrophotometric method for the measurement of 
ribonuclease activity, J Biol Chem. 164, 563-8 
[33] Crestfield AM, Stein WH and Moore S. (1962) On the aggregation of bovine 
pancreatic ribonuclease, Archives of biochemistry and biophysics. Suppl 1, 217-22. 
[34] Greenfield NJ. (2006) Using circular dichroism spectra to estimate protein 
secondary structure, Nature protocols. 1, 2876-90. 
58 
 
[35] Bucci E, Vitagliano L, Barone R, Sorrentino S, D'Alessio G. and Graziano G. 
(2005) On the thermal stability of the two dimeric forms of ribonuclease A, Biophys 
Chem. 116, 89-95. 
[36] Fiorini C, Gotte G, Donnarumma F, Picone D and Donadelli M. (2014) Bovine 
seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic 
cancer cells, Bba-Mol Cell Res. 1843, 976-984. 
[37] Fiorini C, Cordani M, Gotte G, Picone D and  Donadelli M. (2015) Onconase 
induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates 
Akt/mTOR pathway in a ROS-dependent manner, Bba-Mol Cell Res. 1853, 549-560. 
[38] Gotte G, Helmy AM., Ercole C, Spadaccini R, Laurents DV, Donadelli M and 
Picone D. (2012) Double Domain Swapping in Bovine Seminal RNase: Formation 
of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological 
Activities, PloS one. 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
59 
 
 
 
 
 
CHAPTER 
 
2 
 
 
 
 
 
 
 
 
 
60 
 
Engineered C-terminal domain exploited to study the 
pleiotropic effects of hinge loop  
 
 
Abstract 
 
RNase A is a very well characterized protein endowed with the capability to form 
aggregates under well described conditions. Through 3D-DS, RNase A can exchange 
both N-domain and C-domain. This propensity could be strictly related to a high 
flexibility at hinge loops connecting each terminal domain to the protein body. 
Rnasrpirnase (Onconase), an omologue of RNase A whose structural features are 
comparable to those of RNase A, is a highly stable protein with short hinge loops. 
New modifications into the RNase A primary structure were introduced at the C-
terminal hinge loop in order to get insights on the pleiotropic properties of this 
responsive region. The corresponding C-terminal loop of Onconase was used as 
template to design a new mutant, whose stability and swapping tendency were 
compared to those of the native RNase A. Differently from the wild-type RNase A, 
the mutant RNase A- Onc  is able to form dimers spontaneously. This work allowed 
to investigate the relationship between genetic modifications at C-hinge loop and 
protein folding and misfolding. 
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2.1 Introduction 
 
Pronounced modifications and alterations of the protein sequence may modulate both 
the local and global flexibility. Among the possible consequences, the protein 
stability may be affected and the oligomerization may start triggering a “gain of 
structure” or a “loss of structure”. Many proteins are able to self-assembly by 
exchanging domains or secondary structure elements by the so-called 3D domain 
swapping (3D-DS) [1,2]. The structural determinants predictive of a swapping 
attitude are difficult to identify, as they are diverse and subtle. Experimental 
biophysical data coming from X-ray crystallography and NMR, and theoretical 
studies demonstrated the relevant role played in this process by the hinge loop [3,4], 
and by residues constituting the new interface created in the dimerization event, the 
so-called “open interface” [2]. Mutational studies on a relevant number of proteins 
have shown that the shortening or lengthening of the hinge loop can greatly alter 
their propensity to form domain swapped oligomers [4-8]. RNase A still represents 
a useful model to understand the peculiar role of hinge loops in oligomerization by 
3D-DS. Wild-type RNase A, when lyophilized from 40% acetic acid, can swap and 
form either an N-terminal or C-terminal swapped dimer. In the N dimer, the first 
helix swap, whereas in the C dimer, a β-strand is exchanged. The N-terminal hinge 
loop (16-22), which prompts the swapping of the N-terminal helix, consists of 7 
residues, while the C-terminal hinge loop (112-115) is shorter and anchors the C-
terminal β-strand to the rest of the protein [6-8]  In the C-swapped dimer the hinge 
region from each monomer extends to form interactions between β-strands and form 
β-stacking interactions reminiscent of the polar zipper characteristic of amyloid 
fibirils [3]. Eisenberg and coworkers inserted a poly-Q sequence into the hinge 
region resulting in an RNase A that swapped and formed amyloid fibrils. Therefore, 
the role that this region plays for the C-terminal dimerization of RNase A and for 
amyloid formation in the recombinant construct is decisive. This work focused 
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attention on the hinge loop at the C-terminus. This region has been engineered by 
substituting the residues (112-115) of RNase A with the Onconase hinge loop. 
Onconase is an homologous of RNase A, a ribonuclease endowed with interesting 
biological and pharmacological properties, such as cytotoxicity and cytostaticity 
against tumoral cells [9]. Onconase is characterized by a high thermal stability. 
Recently, Vitagliano and coworkers investigated the influence of supersecondary 
associations on the thermal stability in natural proteins [10]. Bioinformatics showed 
that β-hairpins of proteins from thermophilic organisms are characterised by short 
connecting loops [10]. The loop size can be highly correlated with 
chirality/orientation preferences of secondary structure elements. This correlation 
seems to be quite conserved from an evolutionary point of view in thermophilic 
proteins. Moreover, it seems to be particularly relevant for β-loop-β. Both onconase 
and RNase A possess this motif β-loop-β at the C-terminus. In Onconase the C-
terminal hinge loop is shorter than the corresponding region of RNase A. This could 
explain the different stability between the two proteins. Indeed, RNase A has a Tm 
of 62° C against the 90° C measured for Onconase. In collaboration with Drs 
L.Vitagliano and L. Esposito (Institute of Biostructures and Bioimages, CNR, Naples) 
a new RNase A derivative has been designed by genetic modifications at the C-
terminal hinge loop of RNase A by using Onconase C-term loop as template. The 
resulting recombinant protein RNaseA-Onc has been produced and characterised. 
The aggregation propensity of RNaseA-Onc has been also evaluated in comparison 
with that of the wild type RNase A. 
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2.2 Materials and Methods 
 
2.2.1 Production of RNase A mutants: design, cloning, expression 
and purification 
The mutants were designed comparing the sequence of RNase A and ONC. The 
computational analysis and the resulting design were performed by Vitagliano and 
coworkers as previously reported [10]. The synthetic gene encoding RNase A-Onc 
was purchased from GENEWIZ and cloned from the commercial vector pUC57 into 
the expression vector pET22b+ (Novagen). To express the protein, BL21(DE3) cells 
were transformed with the said plasmid. Expression and purification procedures are 
reported in more detail in Section C-1. Recombinant RNase A-Onc was obtained in 
pure monomeric form with a yield of about 12 mg per liter of LB culture medium. 
Protein identity, purity and homogeneity were confirmed by mass spectrometry and 
gel electrophoresis. 
 
2.2.2 Circular dichroism spectroscopy 
For the CD spectra, solutions of  0.15 mg×ml-1 of protein in 0.10 M phosphate buffer 
pH 6.8 were used. The measurements were performed on a JASCO J-810 
spectrometer using a cell with a 0.1 cm path length. The spectra were recorded in the 
range 195-250 nm, with a time constant of 4s, a 2 nm bandwidth, and a scan rate of 
20 nm × min−1. Spectra were signal-averaged over 3 scans and they were baseline 
corrected by subtracting the buffer spectra recorded under the same conditions. 
Thermal unfolding was studied by monitoring the CD signal at 222 nm in the 
temperature range from 25 °C to 85 °C. The scan rate was 0.5 °C × min−1. 
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2.2.3 Size exclusion chromatography 
 
Liophylized pure monomeric RNase A-Onc was dissolved in water at a final 
concentration of 10 mg×ml-1. This stock solution was used to prepare three 
incubation mixtures at a final concentration of 5 mg×ml-1 in three different solvents: 
ultrapure water, sodium phosphate buffer 0.40 M pH 6.7 and acetic acid solution 40% 
v/v. RNase A-Onc was incubated for 2 hours at 25 °C according to the procedure 
described by x and y [11]. After this time, each mixture was loaded on a Superdex 
75 HR 10/30 column attached to an AKTA FPLC system (GE-Healthcare), at room 
temperature, previously equilibrated with 0.40 M sodium phosphate pH 6.7. Elution 
was performed with the same buffer at a flow rate of 0.6 mL ×min-1. 
 
2.2.4 Crystallization and data collection 
 
The crystallographic study was performed by Dr. L. Esposito. The purified protein 
was concentrated to 15 mg× ml -1 in 0.01 M phosphate buffer at pH 6.8. Crystals 
were grown by hanging-drop vapor diffusion at 296 K. The protein solution was 
equilibrated with 0.1 M Bis-Tris pH 6.5, and 28% w/v Polyethylene glycol 
monomethyl ether 2000. A single crystal was transferred to a stabilizing solution 
containing 15% glycerol as cryoprotectant. X-ray data were then collected at 100 K 
using in-house X-ray source. A complete data set (93.6% completeness) was 
collected at 2.31 Å resolution. Data were processed and scaled using the 
DENZO/SCALEPACK package. 
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2.3 Results and Discussion 
 
2.3.1 C-terminus engineered RNase A mutant: background 
and design 
 
The C-terminal hinge loop of Onconase was used as template to design a new mutant, 
RNase A-Onc. As highlighted in Fig.1, the residues GNPYV in RNase A have been 
substituted with the residues NQA, reminiscent of the β-loop-β motif of Onconase. 
 
 
 
Fig. 1 Design of RNase A-Onc. Genetic modification at C-Terminus hinge loops. Wild type RNase 
A and RNaseA.Onc sequences are also reported.  
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2.3.2 C-terminus engineered RNase A mutant: production 
of RNase A-Onc 
 
Recombinant RNase A-Onc was produced  in E.coli BL21 (DE3) transformed with 
a pET22b+ expression vector  containing the corresponding cDNA. The transformed 
cells were grown in LB medium at 37° C until reaching the final OD600 nm of 0.6 
when the protein expression was induced adding 0.4 mM IPTG. After 3 hours from 
the induction, the cells were harvested and subsequently were sonicated to extract 
the protein. The engineered RNase A was accumulated into the inclusion bodies so, 
after lysis by sonication, the cytosolic fraction and the insoluble fraction were 
separated by centrifugation and the following purification procedures were operated 
on the insoluble fraction. After many cycles of sonication and washing with 
detergents (Triton X) and denaturants (Urea), the protein was purified from all the 
endogenous proteins. Subsequently, detergents and denaturants were removed to 
allow the second purification level concerning the refolding under controlled 
conditions. The incubation of the protein using the red/ox couple Glutathion reduced 
and oxyded, was followed to obtain a correctly folded recombinant ribonuclease. 
After 20 hours, the reaction was stopped and the protein solution was loaded on a 
Sephadex G-75 (1.5×72 cm) column equilibrated in 0.1 ammonium acetate buffer 
pH 5.1 in order to purify RNaseA-Onc. The protein was eluted as monomer and its 
molecular weight was assessed on the basis of the elution volume on a G-75 
calibrated column (Fig.2-A). The homogeneity of the sample was also assessed by 
SDS-PAGE and cathodic PAGE. In particular,  as reported in Fig.2-B, the protein 
migrates as a single pure band on the native polyacrilammide gel. Interestingly, it 
migrates more than the wild type RNase A, accordingly to its smaller and more 
compact shape. 
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A                                                                                              B 
 
Fig. 2 Purification of RNase A-Onc. (A) Size exclusion chromatography on a Sephadex G-75 
(1.5×72 cm) column equilibrated in 0.1  ammonium acetate buffer pH 5.1. M: monomer. (B) Cathodic 
gel electrophoresis under non-denaturing conditions. Wild type RNase A is also loaded as reference.  
 
 
2.3.3 Motif  β-loop-β in RNase A-Onc: effects on protein 
stability 
 
The biophysical characterization of RNaseA-Onc was performed using the wild-type 
RNase A as reference. The proper folding of the monomeric form of RNaseA-Onc 
was assessed by circular dichroism spectroscopy. As reported in Fig. 3, at 25 °C the 
CD spectra recorded for the mutant (in red) and the wild type (in black) are 
superimposable, revealing that the recombinant protein is well folded. CD spectra 
recorded at high temperature indicate that RNaseA-Onc (in green) undergoes 
unfolding while retaining a fraction of secondary structure, in line with the observed 
behavior of RNase A (in blu). This behavior was also confirmed by the sigmoidal 
thermal unfolding profiles shown in Fig.4. CD data indicate that the thermal stability 
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of RNaseA-Onc is comparable to the wild-type RNase despite the replacement of the 
key residues Pro114.  Indeed, the T m are 59 °C and 61 °C for RNaseA-Onc and 
RNase A, respectively. 
 
 
Fig. 3. Spectroscopic analysis on RNase A-Onc and RNase A wild type. CD spectra in 0.10 M 
sodium phosphate buffer pH 6.8 at a protein concentration of 0.15 mg×ml-1. The temperature of the 
measurements is also reported with the following color code: 25 °C (RNase A, black), 85 °C (RNase 
A,blu), 25 °C (RNaseA-Onc, red), 85 °C (RNase A-Onc, green).  
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Fig. 4 Spectroscopic analysis on RNase A-Onc and RNase A wild type. Thermal unfolding profiles 
at 222 nm in 0.10 M sodium phosphate buffer pH 6.8 at a protein concentration of 0.15 mg×ml -1 . 
RNase A-Onc and  RNase A are shown in green and in blu, respectively 
 
 
2.3.4 Crystal structure of RNaseA-Onc monomer  
 
The structure of the variant RNaseA-Onc has been solved at 2.3 Å resolution by Drs. 
L. Vitagliano and L. Esposito.  RNaseA-Onc crystals contain three molecules in the 
asymmetric unit that are overall very similar. Indeed, the pairwise superposition of 
C atoms of two molecules (in the range of residues 3-121) yields RMSDs which are 
on average 0.42 Å (chain A-B RMSD=0.35 Å; chain A-C RMSD=0.45 Å; chain B-
C RMSD=0.46 Å). The chain A is the best defined in the electron density out of the 
three, therefore it will serve as the reference model in the following discussion. To 
evaluate the impact of the inserted modification on the RNase A structure, the C 
trace of RNaseA-Onc was superimposed with that of RNase A, excluding the 
segment containing the mutated loop (residues 110-115 in RNaseA-Onc numbering). 
The RMS deviation is 0.37 Å, thus indicating that the fold is essentially unaffected 
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by the shortening and replacement of the loop. The main differences are concentrated 
in the loop region as also highlighted in Fig 5. 
 
     
 
Fig. 5. Ribbon representation of the backbone trace of superimposed RNase A (cyan) and 
RNaseA-Onc (magenta). In yellow is shown the segment 90CENQAP95 of Onconase which 
corresponds to segment 110-115 of RNaseA-Onc.  
 
 
In RNaseA-Onc the modified loop adopts the same conformation of the loop in 
Onconase ; indeed the Cα RMSD for the segment 110-115 is as low as 0.22 Å. 
Specifically, the tetrapeptide E111-A114 forms a β-turn (type I’) in which the two 
central residues (N112 and Q113) adopt unusual  conformations located in the αL  
region of the Ramachandran plot. As for Onconase, the local structure of  RNaseA-
Onc is stabilized  by the hydrogen bonds E111 O…N A114 and E111 N…O A114. 
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Moreover, the side chains of the replaced 112NQA114 residues do not display 
intramolecular interactions, being at the surface of the molecule. Therefore, the 
stabilization of RNaseA-Onc, in line with the design is due to a better adherence to 
the topology rules on the preferred combinations of secondary structure elements.  
  
 
 
 
Fig. 6 The modified loop is shown in stick representation. Superimposed structures of 110-117 
RNase A (cyan), 110-115 RNaseA-Onc (coloured by element: C magenta, O red, N blue, S yellow), 
and 90-95 Onconase (yellow). The two backbone H-bonds between E109 and A114 in RNaseA-Onc  
are also shown as dashed line 
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Furthermore, the electron density of the loop E111-A114 clearly shows that all 
peptide bonds adopt a trans state (Fig. 6). It is important to remember that the 
correspondent N113-P114 in RNase A is in cis state.  
 
 
 
Fig. 6. The omit electron density of the mutated region in RNaseA-Onc is contoured in green. The 
loop 110-115 loop as well as the Cys 58 of the disulfide bridge Cys58-Cys110 are shown in stick 
representations, whereas the rest of the neighboring residues are depicted as lines. 
 
 
 
2.3.5 Aggregation propensity 
 
The aggregation propensity of the recombinant RNase A-Onc has been evaluated.  A 
little amount of protein was incubated in 40% acetic acid solution at a concentration 
of 5 mg×ml-1 for 2 hours at 37 °C and then lyophilized. The powder obtained was 
dissolved in sodium phosphate buffer 0.40 M pH 6.7. As control, a similar amount 
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of protein was dissolved in ultrapure water at a final protein concentration of 5 
mg×ml-1 and incubated at 37 °C for 2 hours. Furthermore, an aliquot of native RNase 
A  was also incubated in acid acid solution 40% v/v and in water for comparison. 
After 2 hours, each protein sample was loaded on a Superdex 75 HR 10/30 column 
attached to an AKTA FPLC system previously equilibrated in sodium phosphate 
buffer 0.40 M pH 6.7. The chromatographic profiles reported in Fig.9, show that 
RNaseA-Onc oligomerizes both under denaturing conditions, i.e upon acetic acid 
liophylization, and under native conditions, i.e. in water.  The 20% of the protein 
was eluted as dimer, independently on the incubation condition. On the other hand, 
as expected RNase A does not give rise to oligomers in ultrapure water but only 
under denaturing conditions, i.e. dissolution in 40% acetic acid solution (Fig.10 ). 
Thus, the chromatographic profiles obtained showed that the mutant RNase A-Onc 
is endowed with a spontaneous aggregation propensity, differently from the parental 
protein. 
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Fig. 9 Gel filtration profiles. RNase A-Onc incubation under native (blue) and denaturing (orange)  
conditions. 
 
Fig. 10 Gel filtration profiles. RNase incubation under native (blue) and denaturing (magenta) 
conditions 
75 
 
2.4 Conclusions and ongoing works 
 
Ribonucleases represent wide-spread models to study protein stability and 
aggregation propensity in vitro. In particular, RNase A is a very well characterised 
protein whose aggregation path is due to the well-known 3D-DS. According to this 
molecular mechanism proposed by Eisenberg, proteins can oligomerize through the  
reciprocal exchange of small or large regions (peptide(s) or entire domain(s)) of the 
monomeric subunits. Monomers exploit short flexible hinge-loops present in their 
sequence to address a definite domain (or more than one) into the corresponding 
partner subunit that will reciprocally swap an identical domain with the former 
subunit. Several studies indicate that hinge loops can be putative regions to trigger 
RNAse A oligomerization via 3D-DS involving both the hinge loops at N-terminus 
and that one at C-terminus. In this work, the role of C-terminal hinge loop sequence 
has been investigated. The short Onconase C-terminal β-hairpin element has been 
used as template to design a new RNase A mutant: RNase A-Onc. The effect of the 
mutations introduced in this sensitive region has been investigated with the aim to 
shed light on the pleiotropic role played by the C-hinge loop in folding/misfolding 
and stability. Biophysical data reveal that the shortness of the loop does not 
compromise the folding and the thermal stability. Moreover, the local structural 
arrangement was not disturbed resulting in a tertiary structure comparable to the 
native RNase A in the region modified. Interestingly, despite the absence of proline 
in this loop, RNase A-Onc shows a spontaneous aggregation propensity. Indeed, it 
forms dimers also under native conditions, i.e. when dissolved in water differently 
from the parental RNase A. According to Laurents and coworkers [12], RNase A is 
chiefly unfolded in 40% acetic acid; indeed even if it partially retains the native 
helices, the β-sheet is fully denatured and all X-Pro peptide bonds are in the trans 
conformation. Refolding occurs via an intermediate, IN, with non-native X-Pro 
peptide bonds. The intermediate is an “activated form” triggering the system to swap 
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domains and oligomerize. In the mutant RNase A-Onc all the peptide bonds in the 
modified hinge loop (i.e. E111-A114) are in trans conformation. This evidence could 
explain why RNaseA-Onc aggregates spontaneously without requiring a 
denaturation step, as revealed by gel-filtration experiments. The  structural 
characterization of these aggregates has not yet been performed, but it is reasonably 
assume that all of them are stabilized through 3D-DS. At any rate, further studies on 
the purified protein forms will provide a deeper characterization of the relationships 
between loop length and flexibility on protein aggregation, folding and stability.  
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State of art 
 
Amyloid-type protein aggregation is an important subject worth of investigation in 
biochemical and biophysical field [1-3].The growth of this research area has been 
improved by the pathological significance of the aggregation events [4-7]. From a 
biophysical point of view, amyloid has attracted attention because of its regular 
fibrous architecture and its correlation to the protein-misfolding problem [8]. 
Amyloidgenesis is the nucleation-dependent aggregation process mostly initiated in 
partially denatured states of amyloidgenic proteins [9-11]. It was also demonstrated 
that the amyloid-like fibrous aggregation with a β-sheet rich structure is a universal 
phenomenon which is not restricted to a special category of proteins [12,13]. Many 
unsolved problems still remain that may be coupled with diversity in the amyloid 
formation mechanisms.  
In this Thesis, the sweet-tasting protein MNEI has been proposed to investigate 
fibrous aggregation.  
MNEI is a single-chain derivative of the sweet protein monellin that, in recent years, 
has become an accepted model for studying protein dynamic properties, folding and 
aggregation [14-17]. Monellin is one of the best-known sweet-tasting proteins; it has 
been first isolated from the fruit of the tropical berry Dioscoreophyllum cumminsii 
by Morris and Cagan at the Monell Institute of California [18]. Monellin is a 
heterodimeric protein composed of two subunits, made of 45 (A chain) and 50 
residues (B chain), respectively [19]. The protein is very stable against acidification 
of the solution, but undergoes heat and chemical denaturation rather easily at neutral 
or alkaline pH [20]. These denaturation processes are often irreversible [20] thus 
hampering industrial applications in food preparations of monellin as edulcorant. In 
order to increase the physicochemical stability and to retain the perceived sweetness, 
two classes of single-chain monellin derivatives have been designed, where the two 
chains are covalently linked [21,22]. The first single-chain monellin designed, 
named SCM, is a protein of 94 residues; it was obtained by directly joining the C-
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terminal residue of B chain (B50E) to the N-terminal residue on the A chain (A1R) 
[21]. The second single-chain monellin, known as MNEI, is a protein of 96 residues 
obtained by linking the A and B chains through the G51-F52 dipeptide [22]. In Fig. 
1 the aminoacidic sequence corresponding to monellin, SCM and MNEI is reported. 
The mutant SCM was the first to be characterized both in the solid state [23] and in 
solution [24]. Structural information about MNEI has been derived from NMR [25] 
and X-ray methods [26]. The topology of MNEI, like that of the parental monellin 
and of SCM, consists of a α-helix cradled into the concave side of a strand of five 
anti-parallel β-sheets [25,26]. The total folding pattern is analogous to a 
pathologically important amyloidgenic protein, cystatin C [27,28]. In Fig. 2, the 
NMR structure of MNEI is reported (PDB code: 1FA3). Even if MNEI was 
engineered to be more stable than the natural monellin against physicochemical 
changes, it shows a prominent aggregation propensity like the parental precursor and 
its homologous SCM [14,15]. ThT fluorescence and TEM show that MNEI gives 
rise to amyloid aggregation upon incubation at high temperature in presence of 0.150 
M NaCl [15]. For this environment-driven aggregation-prone behaviour, MNEI 
represents a widespread model to study the influence of pH, temperature, ionic 
strength on amyloid-like protein aggregation. 
 
 
Monellin 
Chain A: REIKGYEYQLYVYASDKLFRADISEDYKTRGRKLLRFNGPVPP 
Chain B: 
GEWEIIDIGPFTQNLGKFAVDEENKIGQYGRLTFNKVIRPCMKKTIYEEN 
 
SCM 
GEWEIIDIGPFTQNLGKFAVDEENKIGQYGRLTFNKVIRPCMKKTIYEENREIK
GYEYQLYVYASDKLFRADISEDYKTRGRKLLRFNGPVPP 
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MNEI 
GEWEIIDIGPFTQNLGKFAVDEENKIGQYGRLTFNKVIRPCMKKTIYENE(GF)
REIKGYEYQLYVYASDKLFRADISEDYKTRGRKLLRFNGPVPP 
 
Fig. 1 Primary structure of Monellin, SCM and MNEI 
 
 
   
Fig. 2 3D structure of MNEI solved by NMR. PDB code 1FA3. 
Green: A chain ; Orange B chain ; Blue: dipeptide linker GF 
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From monomers to fibres: temperature, pH and ionic 
strength influence MNEI stability 
 
 
Abstract 
 
Several physicochemical factors can influence the solubility of the sweet protein 
MNEI and its aggregation propensity. This study aimed to increase the knowledge 
about the factors that could affect the solubility of MNEI and direct towards different 
kinds of aggregates, corroborating the validity of MNEI as a model to study protein 
aggregation in vitro. An explorative investigation on the influence of the 
environmental changes, i.e. pH, temperature and ionic strength, on the protein 
stability has been performed. These parameters can affect the solubility and improve 
the tendency to form SDS-resistant aggregates. A detailed FT-IR spectroscopy 
analysis allowed monitoring the behaviour of MNEI both in solution and in solid 
state. FT-IR spectroscopy has revealed that MNEI can form aggregates rich in β-
structures. A morphological characterization by AFM has allowed discriminating 
between ordered and amorphous species. New conditions of pH, temperature and 
ionic strength where MNEI gives rise to fibrillar aggregates were found.  
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3.1 Introduction 
 
Protein aggregation is a general, widely observed phenomenon in proteins, but most 
of the times it only leads to the formation of amorphous masses of denatured proteins 
[1]. For biophysicists who study conformational changes of proteins, aggregation has 
often been an artefact disturbing their analyses. However, this situation has largely 
changed recently, since it has become evident that deposits of aggregates of proteins 
or peptides in biological tissues are often correlated with the pathogenesis of 
important human diseases. The conversion of globular native proteins into amyloid 
fibrils represents the crucial pathogenic event of systemic amyloidoses and its 
molecular mechanism has been extensively studied in vitro [2]. For prototypic 
globular amyloidogenic proteins, such as lysozyme [3], transthyretin [4] and wild-
type β2-microgobulin (WT β2m) [5], the fibrillogenesis in vitro is primed by non-
physiological conditions including high temperature, prolonged incubation at acidic 
pH, or addition of organic solvent. Structures of the fibrillar aggregates of several 
amyloidoogenic proteins and the mechanisms of their formation are now one of the 
most attractive subjects of biochemical and biophysical research. In this Thesis, the 
small globular protein MNEI has been proposed as a model to study the 
physicochemical factors that can trigger the system towards different aggregation 
patterns. MNEI is a very well characterized protein and it represents a prototype 
system for many structure-function relationship studies [6],as well as for folding, 
stability and self-assembly investigations [6-8]. Previous experiments carried out on 
this system have shown that MNEI can form amyloid fibrils when heated above its 
Tm at low pH in presence of NaCl [9]. The molecular mechanism leading to the 
fibrous aggregation is still unclear. It has been hypothesized [9], that under these 
conditions MNEI can open by a translocation of   the α-helix; the β- elements become 
more exposed thus favouring the stacking between subunits and the formation of 
higher ordered aggregates.  
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Fig. 1 Schematic model for MNEI aggregation. Image adapted from Esposito et. al (2010) [9] 
 
In this work, an extensive study on the conditions that affect protein stability has 
been pursued. Biochemical and spectroscopic analysis allow monitoring the 
conditions triggering the fibrillar aggregation. In collaboration with Prof. S.M. 
Doglia and Dr. A. Natalello of the University of Milan “Bicocca” a detailed FT-IR 
spectroscopy study has been pursued to screen new conditions where MNEI may 
form fibres. Additionally, in collaboration with Proffs. C. De Rosa and F. Auriemma 
and Dr. R. Di Girolamo, a morphological analysis of the insoluble aggregates by 
AFM has been performed . 
 
3.2 Materials and methods  
 
3.2.1 Production of recombinant MNEI 
To express the recombinant protein, cells of Escherichia coli BL21(DE3) were 
transformed with the expression plasmid pET22b+ containing the cDNA encoding 
for MNEI. Protein expression and purification were performed following the 
procedures reported in Section C “Recombinant Proteins- Procedures”, part 2. 
Protein identity, purity and homogeneity were assessed by mass spectrometry and 
electrophoresis. 
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3.2.2 Sample preparation 
In order to ensure experimental reproducibility, before each experiment MNEI was 
dissolved at a protein concentration of at 10 mg×mL-1 in 1 mM HCl (pH 3.0) and 
incubated at 60 °C for 20 hours. This approach is necessary to increase solubility at 
high protein concentration and to to have an optimal starting point for subsequent 
experiments. 
 
3.2.4 Circular dichroism (CD) spectroscopy 
Circular dichroism measurements have been performed on a Jasco J815 
spectropolarimeter (Jasco, Essex, UK), equipped with a Peltier temperature control 
system, using a 0.1 cm quartz cell. Thermal denaturation experiments were recorded 
following the signal at 215 nm while varying the temperature from 30 to 95 °C at a 
rate of 1 °C×min-1. For each condition, three independent measures were performed. 
Experimental points were fitted to a Boltzmann curve, and fraction of unfolded 
protein (fu) was calculated according to the formula (1): 
 
where θf and θu are the CD signal of the folded and unfolded state from the fitted 
curve, respectively, and θ is the CD signal at each temperature. In all experiments, 
the concentration of MNE was 0.2 mg mL-1 as measured by UV absorbance at 280 
nm using an ε (0.1%) of 1.41. The thermal denaturation curves have been obtained 
at different pHs, namely:  2.5, 3.5, 5.1, 6.8 and 8.4 in 0.020 M sodium phosphate 
buffer. In selected pH conditions, i.e. pH 2.5 and 6.8, the thermal denaturation curves 
were measured for two conditions of ionic strength: 0 and 0.150 M NaCl.  
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3.2.3 Electrophoresis  
MNEI was incubated at a concentration of 5 mg ×mL-1 in 0.020 M sodium phosphate 
buffer at different pHs (2.5, 3.5, 5.1, 6.8, 8.4) with or without 0.150 M NaCl at 
different temperatures (4-37-60 °C) for 2 or 24 hours. At the appropriate time points, 
aliquots of 20 µl were withdrawn from the experimental mixture. The remaining 
sample was centrifuged at 13.000 rpm for 3 min, to separate the soluble and 
unsoluble fractions. The latter one was resuspended in 100 µl of loading buffer. 
Identical volumes (20 µl) of supernatant and precipitated fractions, together with 20 
µl of the total mixture, were then loaded on the same gel, to evaluate protein 
solubility and tendency to form SDS- resistant aggregates. SDS polyacrylamide gel 
electrophoresis (PAGE) was performed according to the Laemmli protocol [10] 
using 15% polyacrylamide gels. The oligomerization patterns were also analysed by 
cathodic electrophoresis under non denaturing conditions using 12% acidic 
polyacrylamide gels [11]. Gels were stained with Coomassie Brilliant Blue R-250. 
 
3.2.5 Fourier Transform Infrared Spectroscopy (FT-IR) 
 
Aliquots of MNEI at 5 mg × mL-1 were incubated from 2 to 24 hours in 0.020 M 
sodium phosphate buffer at different pHs (2.5, 3.5, 5.1, 6.8, 8.4) at different 
temperatures (4-60-75-85 °C) with or without 0.150 M NaCl. The protein 
conformational changes occurring in the time course of MNEI aggregation were 
monitored by FTIR measurements in Attenuated Total Reflection (ATR). For these 
analyses, 2 µl of the protein samples were deposed on the single reflection diamond 
crystal of the ATR device (ATR; Quest, Specac, USA) and dried at room temperature 
in order to obtain a protein hydrated film [12-13] .FT-IR spectra of the hydrated films 
were acquired were collected by the Varian 670-IR spectrometer (Varian Australia 
Pty Ltd, Mulgrave VIC, Australia) under the following parameters: 2 cm-1 resolution, 
scan speed of 25 kHz, 1000 scan coadditions, triangular apodization, and a nitrogen-
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cooled Mercury Cadmium Telluride detector. Spectra were smoothed using the 
Savitsky-Golay method before the second derivative analysis, both performed with 
the Resolutions-Pro software (Varian Australia Pty Ltd., Mulgrave VIC, Australia).  
 
3.2.6 Thioflavin T (ThT) binding assay 
MNEI was incubated at a concentration of 3 mg × mL-1 in 0.020 M sodium phosphate 
buffer pH 2.5 and pH 6.8 at 75 °C with or without 0.150 M NaCl for one week. At 
each aggregation kinetic time point, a sample aliquot was withdrawn and diluted to 
10 µM in 0.020 M sodium phosphate buffer pH 2.5 and pH 6.8 containing 30 µM of 
ThT just before the measurement. Fluorescence emission spectra were acquired on a 
HORIBA Fluoromax spectrofluorimeter in the range 460–600 nm with scan speed 
of 100 nm×min-1, upon excitation at 440 nm. Excitation and emission slits were both 
set at 5 nm. Fluorescence intensity values at 485 nm were normalized with respect 
to the values obtained for a 30 µM ThT sample recorded in the same day, and plotted 
as a function of time. The reported values represent the means from three 
independent experiments. 
 
3.2.7 Atomic Force Microscopy (AFM) 
MNEI was incubated at 3 mg ×mL-1 0.020 M phosphate buffer at pH 2.5 and 6.8 
with or without 0.150 M  NaCl at 75 °C. After one week of incubation, a sample 
aliquot was withdrawn and diluted 100-fold (0.03 mg×mL-1) in ultrapure water, 
deposited on a clean mica sheet and air dried. The mica was then washed with 
ultrapure water to remove any deposited salt and gently dried again. AFM 
measurements were carried on a Bruker Multimode 8. Images were taken in air under 
ambient conditions at a scan frequency of 1 Hz. Scan size was varied from 2 x 2 µm 
to 0.5 x 0.5 µm, depending on sample homogeneity. 
92 
 
3.3 Results and Discussion 
3.3.1 Thermal stability 
In order to evaluate the structural stability of MNEI in a wide range of 
physicochemical conditions, the thermal denaturation profiles were compared by CD 
spectroscopy at five different pH values, 2.5, 3.5, 5.1, 6.8 and 8.4. Full heat 
denaturation curves were acquired by monitoring the CD signal intensity at 215 nm 
over the range 30–90 °C, as described in the experimental section. All the curves 
recorded are consistent with a simple two state equilibrium between folded and 
unfolded forms (Fig. 2). In table 1 are reported the Tm  estimated for each condition 
of pH. 
 
Fig. 1 Spectroscopic analysis at different pHs. Thermal unfolding profiles at 222 nm in 0.020 M 
sodium phosphate buffer pH 2.5 (black), 3.5 (red), 5.1 (blue), 6.8 (magenta), 8.4 (green). 
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Tab. 1 Thermal unfolding parameters. Comparison between the denaturation temperatures of 
MNEI at pH 2.5, 3.5, 5.1, 6.8 and 8.4 
 
CD data show that pH affects thermal stability at different levels. At pH 2.5 MNEI 
is less stable as indicated by its lower Tm; maximum stability is observed  at 
intermediate acidic pHs (3.5 and 5.1).  At neutral (pH 6.8) and alkaline (8.4) pHs, 
stability reverts to values close to those observed at pH 2.5. 
 
3.3.2 Aggregation propensity under non-denaturing 
conditions 
 
Several conditions were firstly explored by SDS-PAGE 15% to assess the 
aggregation propensity of MNEI. As reported in the experimental section, MNEI was 
incubated at a final protein concentration of 5 mg×ml-1 for 2 hours in 0.020 M sodium 
phosphate buffer at different pH (2.5, 5.1, 6.8, 8.4) and at 4, 37 and 60 °C, i.e. at 
temperatures under its Tm. After 2 hours of incubation, aliquot of 20 µl were 
withdrawn for the control, while the remaining parts were centrifuged at 13000 rpm 
for 5 minutes to separate the soluble fraction from the insoluble one.  Identical 
volumes of 20 µl of supernatant and precipitate were then loaded on the same gel. 
pH T m (°C) 
2.5 73 ±1 
3.5 88 ±1 
5.1 86 ±1 
6.8 76 ±1 
8.4 79 ±1 
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As reported in Fig. 2 (panels A-D) a prominent aggregation is revealed in all the 
explored conditions. The oligomers formed in every experimental condition, would 
appear to be SDS resistant.  
The observations deriving from these experiments can be summarized in more 
details as follows: 
- at acidic pH (2.5, panel A) MNEI can form dimers and minor amounts of 
higher oligomers . Higher temperature (60 °C) favours solubility, because the 
amount of insoluble species decreases if compared to the patterns obtained at 
4 or 37 °C; 
- at weakly acidic pH (5.1, panel B), high temperature compromises solubility, 
as indicated by the presence of aggregates into the precipitated fraction. The 
amount of soluble dimer slightly decreases; 
- at neutral pH (6.8, panel C) and alkaline pH (8.4, panel D),  higher size 
insoluble oligomers are predominantly formed. Differently from the acidic 
condition, a temperature increase has a deleterious effect on the protein 
solubility, leading to massive precipitation. Additionally, at pH 8.4, 
significant amount of oligomers of high molecular weight are detected also 
into the upper side of the stacking gel. 
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Fig. 2 MNEI aggregation profiles. Gel-electrophoresis under denaturing conditions (SDS-PAGE 
15%) after 2 h of incubation of MNEI (5 mg×ml-1 ) at 4,37 and 60 °C in sodium phosphate buffer pH 
2.5 (A), pH 5.1 (B), pH 6.8 (C), pH 8.4 (D). T: total; S: supernatant; P: precipitated. Temperatures 
are indicated as superscript. A starting point is also reported and indicated with I: initial point. 
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Fig. 3 MNEI aggregation profiles. Cathodic gel-electrophoresis under non-denaturing conditions 
(native-PAGE 12%) after 2 and 24 h of incubation of MNEI  (5 mg×ml-1 ) at 4 °C (A) and 60 °C (B) 
in 0.020 M sodium phosphate buffer pH 2.5, 5.1, 6.8 and 8.4. M: monomer; D: dimer. 
 
Furthermore, in order to minimize effects related to the SDS treatment that could 
partially dissolve the higher oligomers formed, the behaviour of MNEI was also 
investigated by cathodic PAGE (Fig. 3). MNEI was incubated at a final concentration 
of 5 mg×ml-1 in 0.020 M sodium phosphate buffers at pH 2.5-3.5-5.1-6.8 and 8.4 for 
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2 or 24 hours at 4 °C (panel A) and 60 °C (panel B). As reported in Fig.4-A, lower 
temperature does not affect protein solubility in any of the pH conditions. Indeed 
significant amounts of about 20% of dimer still remain in solution and are detectable 
on gels. Major differences in the aggregation patterns are more remarked at 60 °C 
(Fig.3-B). In particular: 
- at acidic pHs (2.5-3.5 and 5.1), both the monomer and the dimer remain in 
solution after 24 hours; 
- at neutral (6.8) and alkaline (8.4) pHs, the solubility prominently decreases 
in a time dependent way. In fact, after 24 hours, only a little amount of 
monomer is revealed in solution at neutral pH. At alkaline pH, the solubility 
is instantly decreased and after 24h no precipitation is quantitative. 
Comparison of the aggregation patterns obtained by denaturing and non-denaturing 
PAGE reveals that higher oligomers may be detectable only by SDS-denaturing 
electrophoresis upon partial dissolution of these forms that migrate as dimers and 
small size aggregates. On the other hand, besides the monomeric protein, only 
dimeric forms are detectable on the native PAGE because of the low solubility of the 
higher oligomers.  
 
3.3.3 FT-IR spectroscopy: a new tool to study soluble and 
insoluble species 
In order to improve the investigation on the effects of pH and temperature on MNEI 
aggregation, kinetics measurements performed by FT-IR spectroscopy were 
collected. Whit this aim, MNEI was incubated at 5 mg × ml-1 in 0.020 M sodium 
phosphate buffers at pH 2.5- 3.5- 5.1- 6.8- 8.4 at 4 and 60 °C. As described in the 
experimental section, aliquots of 2 µl of samples were deposed on the ATR diamond 
and FT-IR spectra were collected before and after 2-6 and 24 hours of incubation. 
After 24 hours, the mixtures were centrifuged at 13000 rpm for 5 minutes to 
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additionally analyse the precipitated fraction eventually formed during prolonged 
incubation. FT-IR approach allowed monitoring the behaviour of MNEI with an eye 
both on the soluble and insoluble species at the same time thus extending the 
information deriving from the electrophoretic analyses and overcoming the side 
effects of SDS treatment. FT-IR spectroscopy very precisely discriminates between 
closely related protein secondary structures by analysing the Amide I band mainly 
associated with C=O stretching vibrations of the peptide bonds in the 1700-1600 cm-
1 spectral regions [15-17]. Tab. 2 reports the peak positions related to secondary 
structures elements, which were considered during FT-IR analyses to monitor the 
conformational changes.  
Fig. 4 (panels A-D) reports the second derivative spectra acquired at 4 °C. In all the 
conditions of pH explored, MNEI preserves all its secondary structure elements. 
Indeed, the signal around 1660 cm-1 is not affected revealing that the α-helix was not 
perturbed. At the same time, the signal at 1635 cm-1 referred to intramolecular β-
sheets is also preserved even if its intensity slowly increases in a time dependent way 
suggesting that the intramolecular interactions, mainly H-bounds, became weaker 
[16,18]. On the other hand, a shoulder around 1620 cm-1 start appearing: it is 
diagnostic for intermolecular β-sheets and hints aggregation. This negative peak is 
more clearly appreciable into the precipitated fraction isolated by centrifugation after 
24 hours (red lines). This behaviour suggests that a low temperature only a weak 
aggregation occurs even if no significant differences among the pH are significant. 
   
Tab. 2 FT-IR spectroscopy. Spectral regions and secondary structure elements. 
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Fig. 4 MNEI aggregation profile at 4 °C monitored by FT-IR spectroscopy in ATR mode. Second 
derivative spectra recorded after 2-6 and 24 h. MNEI incubation in 0.020 M phosphate buffers at 
different pH: 2.5(A); 5.1 (B); 6.8 (C); 8.4 (D). Each line corresponds to different time of incubation: 
starting point (blue); 2 h (cyan); 6 h (violet); 24 h (green). After 24 h, the supernatant (magenta line) 
and precipitate (red line) are also analysed. 
 
At 60 °C, major differences between acidic, neutral and alkaline pH were observed 
(Fig. 5, panels A-D). As reported in panels A-B, MNEI has a similar behaviour when 
incubated at low and weakly acidic pH, because the comparison of panels A and B 
shows that all the secondary structure elements are conserved and the negative peak 
around 1620 cm-1 is only found after prolonged incubation in the precipitated fraction 
(red lines), suggesting that aggregation occurs slowly.  
 
pH 2.5 
pH 5.1 
pH 6.8 pH 8.4 
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Fig. 5 MNEI aggregation profile at 60 °C monitored by FT-IR spectroscopy in ATR mode. 
Second derivative spectra recorded after 2-6 and 24 h. MNEI incubation in 0.020 M phosphate buffers 
at different pH: 2.5(A); 5.1 (B); 6.8 (C); 8.4 (D). Each line corresponds to different time of incubation: 
starting point (blue); 2 h (cyan); 6 h (violet); 24 h (green). After 24 h, the supernatant (magenta line) 
and precipitate (red line) are also analysed. 
 
Conversely, at neutral and alkaline pH (panels C-D), the aggregation kinetics are 
faster. In more details: at pH 6.8, the negative peak at 1620 cm-1 is detected after 
only 6 hours (panel C, violet line), while at pH 8.4 this diagnostic peak is revealed 
already after 2 hours (panel D, cyan line). Interestingly, at these pHs the looseness 
of α-helix signal and the peak shift from 1635 to 1620 cm-1 were detected already in 
the protein mixture, i.e. without centrifuge the samples. This result suggests that 
aggregation occurs rapidly depriving the solution of the native folded monomeric 
species solution, as revealed by the noisy spectra on the supernatant fraction 
(magenta line).  Interestingly, at 60 °C it was also observed that the intensity of the 
pH 2.5 pH 5.1 
pH 6.8 pH 8.4 
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negative peak at 1620 cm -1 significantly decreases when pH changes suggesting that 
the aggregates are characterised by stronger interactions (H-bounds) between the β- 
elements [16,18]. 
FT-IR spectroscopy clearly reveals the formation of insoluble aggregates confirming 
the behaviours observed by electrophoresis, i.e. that neutral and alkaline pHs deeply 
influence solubility and aggregation. The temperature only affect the rate of the 
process. 
 
3.3.4 The influence of NaCl on the formation of high 
molecular aggregates 
 
We have so far ascertained that pH deeply influences the solubility and the size of 
aggregates and that, at neutral or alkaline pH, temperature accelerates the 
aggregation.  In the following experiments, the influence of ionic strength on the 
aggregation propensity was also investigated. The analyses were restricted to two 
conditions of pH reproducing the acidic and the neutral environment, i.e. pH 2.5 and 
pH 6.8. Thermal stability was assessed by CD spectroscopy, collecting the thermal 
denaturation profiles with or without 0.150 M (Fig.6) at pH 2.5 (panel A) and pH 6.8 
(panel B).  NaCl does not affect the thermal stability of MNEI. In fact, as shown in 
Fig.6 and also summarized in Tab.2, at pH 2.5 (panel A) MNEI increases its Tm of 
3 °C while at pH 6.8 (panel B) no further gain in stability is promoted by the addition 
of salt. 
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A 
B 
Fig. 6  Effects of NaCl on thermal stability.. Thermal unfolding profiles at 222 nm in 0.020 M 
sodium phosphate buffer pH 2.5 (A) and pH 6.8 (B) with or without 0.150 M NaCl. 
 
pH NaCl T m (°C) 
2.5 NO 73 ±1 
2.5 0.150 M 76 ±1 
6.8 NO 76 ±1 
6.8 0.150 M 76 ±1 
Tab.2 Thermal unfolding parameters. Comparison between the denaturation temperatures of 
MNEI at pH 2.5 and 6.8 with or without 0.150 M NaCl 
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In order to evaluate the influence of NaCl on oligomerization, MNEI was incubated 
in these  two conditions of pH, i.e. 2.5 and 6.8 sodium phosphate buffers, with 0.150 
M NaCl at 60 °C, under Tm. The oligomerization has been monitored by cathodic 
electrophoresis under non-denaturing conditions. As reported in Fig.7-A, NaCl 
affects the solubility of MNEI in all the conditions of pH explored.  
 
Fig. 7 MNEI aggregation profiles. Cathodic gel-electrophoresis under non-denaturing conditions 
(native-PAGE 12%) after 2 and 24 h of incubation of MNEI  (5 mg×ml-1 ) at 60 °C in 0.020 M sodium 
phosphate buffer pH 2.5,3.5, 5.1, 6.8 and 8.4 with (A) or without (B) 0.150 M NaCl. M: monomer; 
D: dimer. St: MNEI monomeric form used as reference.   
 
Differently from what observed without NaCl (panel B), no dimers are detectable on 
the gels and the amount of monomers also significantly decreases prolonging the 
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time of incubation, especially at neutral and alkaline pH. This result suggests that 
NaCl triggers the formation of insoluble species. 
 
3.3.5 MNEI fibrillization: new conditions 
It has been reported that MNEI forms fibrillar aggregates at low pH, high 
temperature and by adding 0.150 M NaCl [9]. As described in the previous sections, 
both at acidic and neutral pH, MNEI gives rise to insoluble aggregates characterised 
by intermolecular β-sheets. In this section, new FT-IR spectroscopic analyses were 
aimed to understand if any of the conditions so far explored could lead to the 
formation of ordered fibrils instead of amorphous aggregates. FT-IR spectra were 
collected upon incubation of MNEI at pH 2.5 and 6.8 with or without 0.150 M NaCl 
at 75 °C and 85 °C, i.e. around and above the Tm. Two regions on the IR spectra were 
monitored: 1620 cm-1 (focusing on the diagnostic peak shift from 1635 cm-1) and 
1660 cm -1 (focusing on the looseness of the α-helix signal). The second derivatives 
of the IR absorption spectra at pH 2.5 with or without 0.150 M NaCl at 75 and 85 °C 
are reported in Fig.8 (panels A-D). It is worth to recall that condition D (pH 2.5-
0.150 M NaCl- 85 °C) corresponds to the one investigated by Esposito et al., [9] who 
detected the presence of fibrils by TEM. At 75 °C without NaCl (panel A), a negative 
peak around 1620 cm -1 appears in the sample analysed after 2 hours and 
progressively increases after 4 hours. The signal around 1660 cm-1 was not affected. 
Conversely, whit NaCl (panel B), the negative peak at 1620 cm -1 rapidly appears 
and the signal at 1660 cm -1 disappears already after 2 hours. Specular behaviours 
were observed at 85 °C (panels C-D). The high similarity of the FT-IR patterns 
recorded at 75°C in presence of NaCl with the experimental conditions where MNEI 
forms fibres, suggests that fibres could form also around the Tm. Without NaCl, 
MNEI also shows a pattern diagnostic for fibrillization, even if the overall 
aggregation rate is lower suggesting that NaCl deeply influences the kinetics of the 
process.  
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At neutral pH different behaviours were observed (Fig. 9, panels A-D): by comparing 
the two conditions of ionic strength at 75 ° C (panels A-B), similar aggregation 
patterns are revealed with or without NaCl showing that the formation of 
intermolecular β-sheets and the looseness of α-helix occur very quickly already after 
2 hours. Similarly, MNEI also promptly aggregates at 85 °C whit or without NaCl 
( Panels C-D). All the patterns obtained at neutral pH are also comparable to those 
collected at low pH with NaCl, suggesting that at pH 6.8 the role of NaCl is not so 
decisive. 
 
Fig. 8 MNEI aggregation profiles at pH 2.5 at high temperature with or without NaCl monitored 
by FT-IR spectroscopy. Second derivative spectra recorded for 4 hours. MNEI incubation in 0.020 
M sodium phosphate buffers at: 75 °C without NaCl (A); 75 °C with 0.150 M NaCl (B); 85 °C without 
NaCl (C); 85 °C with 0.150 M NaCl (D). Each line corresponds to different time of incubation: 
starting point (blue); 2 h (purple); 4 h (green). 
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These FT-IR profiles reported that decreasing even at lower temperature, i.e. around 
its Tm , MNEI shows patterns compatible to one obtained in fibrilization condition 
reported in literature. 
 
 
 
Fig. 9 MNEI aggregation profiles at pH 6.8 at high temperature with or without NaCl monitored 
by FT-IR spectroscopy. Second derivative spectra recorded for 4 hours. MNEI incubation in 0.020 
M sodium phosphate buffers at: 75 °C without NaCl (A); 75 °C with 0.150 M NaCl (B); 85 °C without 
NaCl (C); 85 °C with 0.150 M NaCl (D). Each line corresponds to different time of incubation: 
starting point (blue); 2 h (purple); 4 h (green). 
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3.3.5 ThT binding 
Electrophoretic data provide a rational basis to select new conditions of pH, 
temperature and ionic strength leading to insoluble species. FT-IR restrict the 
investigation on the conditions triggering fibrilization. Indeed, it suggests that both 
at acidic and neutral pH at 75 °C, intermolecular β-sheet can form with or without 
NaCl and α-helix signal also progressively disappears. These behaviours may hints 
the formation of fibrillar structures. A common hallmark of fibrillar aggregates rich 
in β-elements is the capability to bind Thioflavin T (ThT). Thus, preliminary checks 
were pursued by evaluating the ThT binding on β structures thorough a fluorescence 
assay. MNEI has been dissolved at 3 mg×ml-1 in 0.020 M sodium phosphate at pH 
2.5 and pH 6.8, with and without 0.150 M NaCl and incubated at 75 °C until one 
week (168 hours) . At this time, a clear ThT fluorescence intensity plateau was 
detected. ThT fluorescence intensities in function of time are reported in Fig.10, 
panels A-B. In all the conditions explored, a positive ThT fluorescence signals were 
detected but some differences in the kinetics of ThT binding are revealed.  
a) ThT fluorescence emission was pH dependent. In fact, at acidic pH (panel A) 
the kinetics is lower than what observed at neutral pH (panel B), where the 
fluorescence reaches plateau very fast, already after 24 hours of incubation 
while at pH 2.5 the plateau is detectable after one week. 
b) The ionic strength deeply influence the formation of ThT+ aggregates at 
acidic pH (panel A). In fact with NaCl at pH 2.5 the ThT fluorescence 
intensities progressively for one week. Without NaCl the kinetics of ThT 
binding is slower. At neutral pH (panel B) no significant differences among 
the two conditions of ionic strength are appreciable at the end point.  
 
In both the conditions of pH considered, no lag phases were detected suggesting that 
the aggregation is very fast. These results are in accordance with the biochemical 
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and spectroscopic studies previously described. Furthermore, this behavior could 
hint the formation of amyloid-like aggregates also close to Tm .  
A  
      B        
Thioflavin T binding assay. Fluorescence intensity at 485 nm upon incubation of MNEI (3 mg×mL-
1 )  at 75 °C in 0.020 sodium phosphate buffer pH 2.5 (A) and pH 6.8 (B) with or without 0.150 M 
NaCl for one week. 
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3.3.6 Fibres and amorphous species 
In order to reveal the nature of the insoluble aggregates formed close to the Tm ,a 
morphological investigation has been performed by AFM, choosing to use 75 °C as 
incubation temperature at pH 2.5 and pH 6.8 with or without 0.150 M NaCl for one 
week. The AFM images were acquired  by Dr. R. Di Girolamo. As reported in Fig.10 
(panels A-B) at 75° C, fibres were detected at pH 2.5 with or without NaCl 
corroborating the data deriving from FT-IR analyses and the aggregation kinetics 
followed by ThT mesaurements.  On the other hand, as reported in Fig.11 (panel A-
B) only disordered aggregates were detected at neutral pH with or without salt. This 
behaviour is in accordance with the biochemical and spectroscopic data that revealed 
a too fast aggregation, also confirmed by the early plateau detected by ThT 
measurements. At neutral pH the system evolves towards disordered species that 
rapidly collapse into an amorphous precipitated form. 
 
 
 
 
110 
 
  A 
B 
       
Fig. 10 Morphology characterization by AFM at pH 2.5. MNEI fibres upon incubation in 0.020 M 
sodium phosphate buffer pH 2.5 at 75 °C with 0.150 M NaCl (A) or without NaCl (B). A zoom section 
of the fibres is also reported. 
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A                                                                      B 
Fig. 11 Morphology characterization by AFM at pH 6.8.  MNEI amorphous aggregates upon 
incubation in 0.020 M sodium phosphate buffer pH 6.8 at 75 °C with 0.150 M NaCl (A) or without 
NaCl (B).  
 
3.4 Conclusions and ongoing works 
 
In this study, a very careful exploration of MNEI aggregation has been performed. 
Several physicochemical factors have been investigated, including pH, temperature 
and ionic strength. Biochemical and FT-IR spectroscopic data reveal that MNEI 
shows a remarkable aggregation propensity, that can be powerfully influenced by 
different factors. At low temperature, MNEI is stable in solution in all the pHs 
examined and only a little amount of dimer is detectable in solution. When the 
temperature is increased, MNEI rapidly oligomerizes giving rise to high size species 
that are endowed with a surprising SDS resistance. Around its Tm , MNEI forms 
insoluble aggregates which show a typical FT-IR profile found in fibrillar structures, 
i.e. the peak shift from 1635 cm-1 to 1620 cm-1  and the looseness of the signal around 
1660 cm-1 , which ar diagnostic of the formation of intermolecular β-sheets and the 
disappearing of the native α-helix. FT-IR spectroscopy allows to define new 
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conditions triggering fibrilization. Indeed, fibrillar-like profiles were detected at 
75 °C at pH 2.5 whit 0.150 M NaCl; the profiles collected without NaCl hints that 
fibrilization could occur also without NaCl even if the lag phase was slower. These 
suggestions were confirmed by ThT binding assays where high fluorescence 
intensities were detected after one week. A similar fibrillar-like behaviour was also 
observed at neutral pH even if the aggregation occurs very quickly whit or whitout 
NaCl, as revealed by FT-IR spectroscopy and ThT assay. In order to resolve the 
morphology of these insoluble aggregates, an AFM analysis was performed. It has 
been found that at low pH MNEI forms ordered aggregates with or without NaCl, 
thus supporting the biochemical and spectroscopic data. Indeed, they are SDS 
resistant. Additionally they show a negative peak of very low intensity on FT-IR 
curves around 1620 cm-1, suggesting that several weak interactions (H-bonds) 
strongly connect the β-elements in an ordered structure. On the other hand, at neutral 
pH the system evolves towards disordered species with or without NaCl. In this 
condition, the aggregation occurs too fast and the system collapses into an 
amorphous precipitated form. The influence of pH, temperature and ionic strength is 
worth of further investigation. The understanding of the behaviour of MNEI under 
new environmental conditions triggering fibrilization could allow understanding the 
underlying molecular mechanism. A better knowledge could also support a rational 
design of new mutants endowed with controlled aggregation propensity, as well as 
support new biotechnological applications in the field of biopolymers.  
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MNEI early steps of unfolding: new NMR insight 
 
Abstract 
 
MNEI aggregation propensity can be evaluated at different level, since the protein is 
able to form a wide range of aggregates making it a suitable model to study the 
oligomerization process in vitro. Even if more stable than the parental protein 
monellin, MNEI is an aggregation prone protein which, like its natural precursor, is  
able to form fibrillar aggregates. In Chapter 3, a deep explorative study allowed to 
find new conditions favouring fibrilization under prolonged incubation at acidic pH 
around its Tm, with or without NaCl. In order to depict the correlation between 
folding intermediates and the beginning of aggregation process, NMR studies have 
been pursued. The analysis aimed to identify the early steps of unfolding process at 
atomic detail to explain the fibrilization propensity under different experimental 
conditions, i.e.  evaluating the influence of temperature and ionic strength at acidic 
pH, where MNEI is able to form ordered aggregates. 
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4.1 Introduction 
 
MNEI and its derivatives have been proposed as potential low-caloric sugar replacers 
for food and beverages, but their usage in this framework has been slowed down by 
their intrinsic structural fragility. Although displaying higher thermal stability than 
the heterodimeric natural precursor monellin [1], MNEI is still sensitive to pH and 
temperature changes, that can trigger its unfolding, aggregation and precipitation, 
thus reducing its usage for food preparation [2,3,4]. In recent years, MNEI has also 
become a well-accepted model to study folding and aggregation properties of β-
sheet-rich proteins. In particular, the dynamics of the folding and unfolding 
processes have been studied in great detail instance by the Udgaonkar group [5,6,7]. 
It had been previously found that the stability of MNEI at neutral pH is determined 
by the protonation state of residue Glu23, located in a hydrophobic pocket and 
possessing a pKa around 7.5 [8]. The anomalous value of this pKa is explained by 
the general observation that side chains of acidic residues embedded in hydrophobic 
environments titrate with high pKa, whereas the opposite behaviour is observed for 
basic residues. Furthermore, it is generally reported that residues located within 
hydrophobic pockets control the pH-dependent stability in proteins [9,10]. Very 
recently Molecular Dynamic simulation studies at high temperature showed, that 
deprotonation of Glu23 increases flexibility in loop Lα2, which connects the helix to 
the β-strand 2, and leads to the disruption of a stabilising hydrogen bond zipper 
between side chains and, in turn, lowers the thermal stability of the protein [12]. This 
study had been confirmed experimentally by NMR; furthermore it has been found 
that the proton chemical shift of the side-chain of Gln28 follows exactly the titration 
of Glu23 [13] resulting in a rigid structure at acidic pH and more flexible one at 
alkaline pH. 
As discussed in Chapter 3, MNEI is highly sensitive to changes in pH and 
temperature that can result in aggregation and/or precipitation. Biochemical and 
biophysical studies previously described in Chapter 3, revealed that MNEI at low pH 
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can form a little amount of soluble dimer. Increasing temperature MNEI can form 
unsoluble fibrillar aggregates. At high temperature and low pH, the presence of NaCl 
accelerates the fibrilization. On the other hand, at neutral pH the amount of monomer 
in solution rapidly decreases and the system evolves towards unsoluble and 
amorphous species. In this study, the behaviour of MNEI at acidic pH has been 
analysed in more detail. High resolution NMR studies have been performed to 
investigate the role of temperature and ionic strength on the early unfolding events 
of MNEI. NMR analysis have been performed in collaboration with Dr. D.V. 
Laurents of the CSIC-IQFR (Consejo Superior de Investigation Cientificas - Istituto 
de Quimica-Fisica “Rocasolano”) in Madrid.  
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4.2 Materials and Methods 
 
4.2.1 Protein expression and purification 
 
The protein, MNEI, was expressed in Escherichia coli  BL21 (DE3) cells harbouring 
the pET-22b+ plasmid and purified as described in Section C “Recombinant 
Proteins- Procedures”, part 2. The 15N 13C labelled protein was expressed in M9 
medium containing 0.5 g×l-1  of 15NH4Cl and  20 g×l
-1 of 13C-glucose as sources of 
labelled nitrogen and carbon, respectively. Sample purity and folding were 
confirmed by SDS/PAGE, gel-filtration, circular dichroism and mass spectrometry 
analysis. Protein secondary structure elements are described according to the 
following nomenclature: Nt (1–3), β1 (4–6), Lα1 (7–9),α1 (10–27), Lα2 (28–34), β2 
(35–48), L23 (49–54), β3 (55–64), L34 (65–68), β4 (69-78), L45 (79–83), β5 (84–
90), Ct (91–96). 
 
4.2.2 NMR spectroscopy 
 
15N 13C-MNEI was dissolved in 0.020 M sodium phosphate buffer pH 2.9, 10% D2O 
at 5 mg×ml-1 for reference spectrum. 0.1 mM DSS salt was added for internal 
referencing Standard experiments commonly used for protein assignment were 
performed at 35 °C, including 15N HSQC, CACB(CO)N(H), HNCO, HNCA, HNN 
and HNH spectra. The assignment process was carried out manually using Sparky 
software (T. D. Goddard and D. G. Kneller, SPARKY 3,University of California, 
San Francisco). To follow chemical shift variations as function of temperature or 
ionic strength, series of 15N-HSQC spectra were acquired by dissolving  MNEI  in 
and the same buffer used for the assignment  at a concentration of 2.5 mg×mL-1.  
Spectra were acquired by increasing the temperature from  35-45-55-65 °C, and then 
going back from 65 to 35 °C with or without 0.150 M NaCl. All the spectra were 
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acquired using a Bruker Avance II 800 MHz spectrometer equipped with triple axis 
gradient cryo-probe. Chemical shift variations were calculated as weighted averages 
of overall backbone amides between 35 °C and 45 °C, 35 °C and 55 °C and between 
35 °C and 65 °C using the formula:  
 
 
 
 
 
4.2.3 Hydrogen/ Deuterium exchange 
Hydrogen exchange experiments were performed dissolving the labelled MNEI in 
99.9% D2O at pH 2.9 with or without 0.150 M NaCl. A series of successive              
15N-HSQC spectra was recorded at 35 °C  for 20 hours using a Bruker Avance 600 
MHz spectrometer equipped with cryoprobe. 
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4.3 Results and Discussion 
 
4.3.1 HSQC spectrum at high magnetic field 
 
MNEI 15N-13C was dissolved at a final concentration of 5 mg×ml-1 in sodium 
phosphate buffer pH 2.5 to acquire a full dataset necessary to complete the 
assignment at 35 °C, as described in the experimental section. The 15N-HSQC 
spectrum reported in Fig. 1 indicate that all the residues were identified. The 
spectrum acquired in this conditions has been used as reference to identify the amide 
and proton chemical shift variations in different experimental conditions of 
temperature and ionic strength. 
 
 
 
Fig. 1 15N-HSQC spectrum of MNEI at 35 °C 
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4.3.2 Temperature effect 
 
With the aim to investigate at atomic detail the variations on tertiary structure 
occurring when temperature was changing, 15N-HSQC spectra were acquired by 
increasing progressively the temperature of 10° C, i.e from 35 to 45 °C, from 45 to 
55 °C and from 55 to 65 °C. At the end, an additional spectrum was acquired cooling 
back the sample to the starting point, i.e.  decreasing temperature from 65 to 35 °C. 
In order to find the putative regions involved in local unfolding events, the shift of 
the resonances of amide and proton chemical shifts for each aminoacidic residue 
have been calculated for each range of temperature. Fig. 2 summarizes the chemical 
shift variations upon heating of MNEI when temperature was increased from 35 to 
45 °C (blue bars), from 35 to 55 °C (green bars) and from 35 to 65 °C (red bars). The 
secondary structure elements are also reported on the top of the figure, using the 
following color-code: loop (magenta), α-helix (grey), β-sheet (yellow). 
 
 
Fig. 2 Chemical shift variations (Δ avg) upon MNEI heating. The temperature was increased of 
10 °C (blue), 20 °C (green) and 30 °C (red), progressively. Missing values correspond to peaks not 
assigned for overlap/broadening.  
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As indicated by the blue bars, when temperature was increased of 10 °C, only the 
residues located in loop regions show significant chemical shifts variations. By 
increasing the temperature of additional 10 °C, until 55 °C (green bars), it can be 
observed that loop regions are still influenced, together C41. Furthermore, the signals 
relative to residues D7 (Lα1), A19 (α1), E50-R53-E54 (L23) and F89 (β5) were 
shifted in very crowded region of the spectrum (8.3-8.0 ppm on 1H axis, 123-118 
ppm on 15N axis), making difficult their identification. When temperature was 
increased until 65 °C (red bars), besides the loop regions and C41 (β2), also the 
residues located in β4 (I75-S76- E77- D78-Y79) and β5 (R84-L86) significantly 
change their positions.  
Interestingly, MNEI signals were completely recovered when the temperature was 
decreased from 65 °C to 35 °C (data not shown) suggesting that, the protein 
completely refolds and its 3D structure is completely restored.  
 
 
4.3.3 NaCl effect 
 
In order to extend the analysis at acidic pH, the influence of NaCl on MNEI stability 
has been also investigated. A set of 15N-HSQC spectra were acquired following the 
peak positions upon increasing temperature from 35 °C to 65 °C as previously 
described. When 0.150 M NaCl was added, the better quality of the spectra allowed 
to carefully assign the residues when temperature was increased. The amide and 
proton chemical shift variations upon MNEI heating were calculated and were 
reported on histograms (Fig. 3). Blue bars correspond to chemical shift variations 
calculated when temperature was increased of 10 °C (i.e. from 35 to 45 °C), green 
bars correspond to chemical shift variations calculated when temperature was 
increased of 20 °C (i.e. from 35 to 55 °C) while red bars are relative to chemical shift 
variations observed when temperature was increased of 30 °C (i.e. from 35 to 65 °C). 
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The secondary structure elements are also reported: loop (magenta), α-helix (grey), 
β-sheet (yellow). 
 
 
Fig. 3 Chemical shift variations (Δ avg) upon MNEI heating with NaCl 150 mM. The temperature 
was increased of 10 °C (A), 20 °C (B) and 30 °C (C), progressively. Missing values correspond to 
peaks difficult to assign.  
 
When temperature was increased of 10 °C (blue bars), only a few residues belonging 
to the loop regions and the residues R88-F89 located in β5 show significant amide 
chemical shift variations. By increasing the temperature of further 10 °C reaching 
55 °C (in green), loop regions are still deeply influenced as revealed by their high 
chemical shift variations; additionally, the signal for G51 disappears. Residues R88 
and F89 are still characterised by high chemical shift variations together with F71 
which is located in β4 strand. Finally, when temperature was increased up to 65 °C 
(in red) all the loop regions are strongly influenced; in more detail, the signal of 
residues located in the loop 23, i.e. 49-54, become very broad and are no more 
detectable in the spectrum. Moreover, high chemical shift variations were detected 
for K43 in β2 and for many residues located in β4 and β5 strands, suggesting that 
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also in presence of NaCl, this region has a primary importance in the early unfolding 
of MNEI. 
To make more clearly evident the local effects of the temperature increase, the 
residues whose resonances are affected by a value higher than 0.2 ppm (selected 
arbitrarily as threashold, are highlighted in the Fig. 4 (panel A: no NACl added, panel 
B: 150 mM NaCl)   
 
A  
B  
Fig.4 Topological maps. Local effects of temperature on MNEI at pH 2.5 without NaCl (A) and with 
0.150 M NaCl (B). In green: the most stable residues. In red: the most affected residues without NaCl. 
In blue: the most affected residues with 0.150 M NaCl. 
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4.3.4 Stability and compactness: H/D exchange experiments 
 
Detailed information on MNEI solvent accessibility was derived from H/D exchange 
experiments. 15N MNEI was dissolved in 99% D2O at pH 2.9 and a series of HSQC 
data sets was collected at 35 °C every 40 minutes for 20 hours. Based on the intensity 
of HN signal over time, the amide protons were classified as fast or slow exchanging. 
In detail, peaks that disappeared soon after the protein dissolution, i.e. were absent 
already in the first spectrum acquired in D2O, were classified as fast-exchanging. 
Peaks that were still present in the last spectrum, i.e. 20 hours after the protein 
dissolution in D2O, were classified as slow-exchanging. All other peaks detected 
were considered as medium-exchanging ones. In Fig. 6 and 7, the topological maps 
of MNEI comparing the H/D exchange with or without NaCl are reported. The slow 
exchanging residues are highlighted with the following color-code:  
 
- green: absent at the beginning, i.e. high accessibility; 
- red: still present at the beginning, i.e. medium accessibility; 
- blue: still present after 20 hours, i.e. low accessibility.  
 
In Tab.1 and Tab.2 a detailed classification of each residue is reported by estimating 
the H/D exchange at different time in both the condition of ionic strength explored, 
i.e. 0 mM NaCl in Tab.1 and 150 mM NaCl in Tab.2, respectively. After 20 hours, 
only few residues were detected including: 4E- I6 (β1), A19-I26 (α1), V37-I38-R39 
(β2),E54-E59-Y60-Q61-L62-Y63-V64-Y65-A66 (β3), L70-F71-R72-I75 (β4), L87-
V93 (C-t). In the sample containing 0.150 M NaCl, more residues are classified slow 
exchangers, including Q13-L15-G16-K17-V20-E22-E23 (α1), N35-K36-V37-I38-
M42-K43-T45-I46-E48 (β2), E54-K56-Y58-E59-Y60-Q61-L62-V64-Y65 (β3), 
K69-L70-F71-D74-I75-S76 (β4), L87-N90 (β5) and V93 (Ct) (Fig.7). Overall, the 
comparison between these experiments suggest that MNEI is more compact and rigid 
with NaCl. 
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Tab. 1 H/D exchange experiments at pH 2.9 (noNaCl added). Classification of residues as Fast 
(F), Intermediate (I) and Slow (S) exchangers. Time of HSQC spectra acquisition is also reported: t 1 
and t 2, corresponding to 40 minutes and 20 hours after dissolution of MNEI in D2O.  
(x): identification; (-): no identification 
 
 
 
 
Aa t 1 
40’ 
t 2 
20h 
H/D 
exchange 
Aa t 
1 
t 2 
20h 
H/D 
exchange 
Aa t 1 
40’ 
t 2 
20h 
H/D 
exchange 
G1 - - F L32 x - I Y63 x x S 
E2 - - F T33 - - F V64 x x S 
W3 - - F F34 - - F Y65 x x S 
E4 x x S N35 - - F A66 x x S 
I5 x - I K36 - - F S67 - - F 
I6 x x S V37 x x S D68 - - F 
D7 - - F I38 x x S K69 - - F 
I8 - - F R39 x x S L70 x x S 
G9 - - F C41 - - F F71 x x S 
F11 - - F M42 - - F R72 x x S 
T12 - - F K43 - - F A73 - - F 
Q13 x - I K44 - - F D74 - - F 
N14 - - F T45 x - I I75 x x S 
L15 x x S I46 - - F S76 x - I 
G16 - - F Y47 - - F E77 - - F 
K17 - - S E48 - - F D78 - - F 
F18 x - I N49 - - F Y79 - - F 
A19 x x S E50 - - F K80 - - F 
V20 x x S G51 - - F T81 - - F 
D21 - - F F52 - - F R82 - - F 
E22 - - F R53 - - F G83 - - F 
E23 - - F E54 x x S R84 - - F 
N24 - - F I55 - - F K85 - - F 
K25 - - F K56 x - I L86 - - F 
I26 x x S G57 - - F L87 x - I 
G27 - - F Y58 x - I R88 x - I 
Q28 - - F E59 x x S F89 - - F 
Y29 - - F Y60 x x S N90 - - F 
G30 - - F Q61 x x S G91 - - F 
R31 - - F L62 x x S V93 x - I 
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Tab. 2 H/D exchange experiments at pH 2.9 containing 150 mM NaCl. Classification of residues 
as Fast  
(F), Intermediate (I) and Slow (S) exchangers. Time of HSQC spectra acquisition is also reported: t 1 
and t 2, corresponding to 40 minutes and 20 hours after dissolution of MNEI in D2O. 
 (x): identification; (-): no identification. 
 
 
 
Aa t 1 
40’ 
t 2 
20h 
H/D 
exchange 
Aa t 1 
40’ 
t 2 
20h 
H/D 
exchange 
Aa t 1 
40’ 
t 2 
20h 
H/D 
exchange 
G1 - - F L32 x - I Y63 - - F 
E2 x x S T33 x - I V64 x x S 
W3 - - F F34 - - F Y65 x x S 
E4 x x I N35 x x S A66 x x S 
I5 x - I K36 x x S S67 x - I 
I6 x x S V37 x x S D68 - - F 
D7 - - F I38 x x S K69 x x S 
I8 - - F R39 x - I L70 x x S 
G9 x - I C41 - - F F71 x x S 
F11 - - F M42 x x S R72 - - F 
T12 - - F K43 x x S A73 - - F 
Q13 x x S K44 - - F D74 x x S 
N14 x - I T45 x x S I75 x x S 
L15 x x S I46 x x S S76 - - F 
G16 x x S Y47 - - F E77 x - I 
K17 x x S E48 x x S D78 - - F 
F18 x x S N49 - - F Y79 - - F 
A19 - x F E50 - - F K80 - - F 
V20 x x S G51 - - F T81 - - F 
D21 x - I F52 - - F R82 - - F 
E22 x x S R53 - - F G83 - - F 
E23 - - F E54 x x S R84 - - F 
N24 - - F I55 - - F K85 - - F 
K25 x - I K56 x x S L86 - - F 
I26 x - I G57 - - F L87 x x S 
G27 - - F Y58 x x S R88 x - I 
Q28 - - F E59 x x S F89 - - F 
Y29 - - F Y60 x x S N90 x x S 
G30 - - F Q61 x x S G91 - - F 
R31 - - F L62 x x S V93 x x S 
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Fig. 6 Topological maps of MNEI. H/D exchange experiments at pH 2.9 without NaCl. Fast 
exchanger residues (green); intermediate exchanger residues still present at the starting point (red); 
low exchanger residues still present after 20 hours (blue) 
 
          
Fig.7 Topological maps of MNEI. H/D exchange experiments at pH 2.9 with 150 mM NaCl. Fast 
exchanger residues (green); intermediate exchanger residues still present at the starting point (red); 
low exchanger residues still present after 20 hours (blue) 
 
 
 
By comparing the information obtained from temperature titration experiments and 
from the H/D exchange measurements, putative regions of early unfolding steps were 
identified. In both the conditions of ionic strength explored, except form the loop 
regions, which are naturally more influenced by environment, the aminoacid residues 
located in β4 (I75-S76- E77- D78-Y79) and β5 strands ( R84-L86) were strongly 
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affected by temperature increasing, as revealed by high chemical shift variation 
values. At the same time, they were also in a fast H/D exchanging regime and more 
accessible to the solvent. Since these residues are more affected by the 
physicochemical variations analysed, based on this analysis it is possible to 
hypothesize that the terminal part of β4 and the initial part of β5 strands could 
represent a putative site for early unfolding.  
 
 
 
4.4 Conclusions and ongoing works 
 
This work investigated, for the first time by NMR, the influence of temperature and 
ionic strength on MNEI folding/misfolding at low pH. As reported in previous works, 
at low pH at 86 °C, in the presence of 0.150 M  NaCl, MNEI forms fibres [14], 
reproducing the behaviour of its natural precursor monellin [15-16]. In Chapter 3, it 
has also been described that at acidic pH, MNEI fibrilization also occurs by 
decreasing temperature from 86 °C to 75 °C, the last one corresponding to MNEI 
melting temperature at pH 2.5. Moreover, data discussed in the same Chapter 3, 
indicated that MNEI forms ordered aggregates with or without NaCl, although a 
prolonged incubation time is required. In order to investigate the influence of 
temperature and ionic strength on the unfolding of MNEI, NMR measurements have 
been performed. NMR analysis reveals that MNEI is more compact and rigid in 
presence of NaCl than without salt. High-resolution experiments showed that, as 
expected, the main chemical shift perturbations occur primarily into the loop regions. 
In more detail, the assignment was cryptic in the loop region L23 (49-54) 
corresponding to the engineered linker; indeed when temperature was increased the 
signals fall in a crowded region of the spectra precluding their identification. 
Focusing the attention on the structured regions of MNEI, the analysis of proton and 
amide chemical shift variations allowed to individuate the residues located in β4 
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(I75-S76- E77- D78-Y79) and β5 strands ( R84-L86), corresponding to the C-
terminal and the N-terminal part of these two β-strands, as the most affected by the 
experimental conditions examined.  H/D exchange experiments also confirmed that 
this region is more exposed to the solvent being in a fast exchanging regime with 
D2O. The results confirm that these regions could be putative sites for early unfolding 
of MNEI.  
Further NMR studies increasing temperature until 75 °C where MNEI forms fibres, 
as described in Chapter 3, could help to a better understanding of the correlation 
between unfolding and aggregation. Additionally studies at neutral may allow 
shedding light on the differences that in such a case lead to the formation of 
disordered aggregates.  
Finally, these data provide structural hints to understand how  temperature/pH/ionic 
strength can modulate the formation of ordered aggregates of MNEI, which could 
drive the design of new mutants with improved resistance to physicochemical stress 
or even  with potential applications as new protein-based biomaterials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
132 
 
4.5 References  
 
[1] Morris JA and Cagan RH (1972) Purification of monellin, the sweet principle of 
Dioscoreophyllum cumminsii. Biochim Biophys Acta (BBA) – General Subjects 261, 
114–122. 
[2] Aghera N, Earanna N and Udgaonkar JB (2011) Equilibrium unfolding studies 
of Monellin: the doublechain variant appears to be more stable than the singlechain 
variant. Biochemistry 50, 2434–2444. 
[3] Aghera N and Udgaonkar JB (2012) Kinetic studies of the folding of 
heterodimeric monellin: evidence for switching between alternative parallel 
pathways. Mol Biol 420, 235–250. 
[4] Aghera N and Udgaonkar JB (2013) The utilization of competing unfolding 
pathways of monellin is dictated by enthalpic barriers.Biochemistry 52, 5770–5779. 
[5] Goluguri RR and Udgaonkar JB (2015) Rise of the helix from a collapsed globule 
during the folding of monellin. Biochemistry 54, 5356–5365. 
[6] Jha SK, Dhar D, Krishnamoorthy G and Udgaonkar JB (2009) Continuous 
dissolution of structure during the unfolding of a small protein Proc Natl Acad 
SciUSA 106, 11113–11118. 
[7] Rega MF, Di Monaco R, Leone S, Donnarumma F, Spadaccini R, Cavella S and 
Picone D (2015) Design of sweet protein based sweeteners: Hints from structure– 
function relationships. Food Chem 173, 1179–1186. 
[8] Spadaccini R, Crescenzi O, Tancredi T, De Casamassimi N, Saviano G, 
Scognamiglio R, Di Donato A and Temussi PA (2001) Solution structure of a sweet 
protein: NMR study of MNEI, a single chain monellin. J Mol Biol 305, 505–514. 
133 
 
[9] Garcia-Seisdedos H, Ibarra-Molero B and Sanchez- Ruiz JM (2012) How many 
ionizable groups can sit on a protein hydrophobic core? Proteins 80, 1–7. 
[10] Harms MJ, Casta~neda CA, Schlessman JL, Sue GR, Isom DG, Cannon BR and 
Garcıa-Moreno EB (2009) The pKa values of acidic and basic residues buried at the 
same internal location in a protein are governed by different factors. J Mol Biol 389, 
34–47. 
[11] Langsetmo K, Fuchs JA and Woodward C (1991) The conserved, buried 
aspartic acid in oxidized Escherichia coli thioredoxin has a pKa of 7.5. Its titration 
produces a related shift in global stability. Biochemistry 30, 7603–7609.  
[12] Leone S and Picone D (2016)  Molecular dynamics driven design of pH-
stabilized mutants of MNEI, a sweet proteinPLoS One 11, e0158372. 
[13] Spadaccini R, Leone S,Rega MF, Richter C and Picone S. (2016) Influence of 
pH on MNEI structure and stability. FEBS Letters 590 3681–3689 
[14] Esposito V, Guglielmi F, Martin SR, Pauwels K, Pastore A, Piccoli R, Temussi 
PA., (2010) Aggregation mechanisms of cystatins: a comparative study of monellin 
and oryzacystatin. Biochemistry. 6;49(13) 
[15] Konno T, Murata K and Nagayama K (1999) Amyloid-like aggregates of a plant 
protein: a case of a sweet-tasting protein, monellin. FEBS Lett 454, 122–126. 
[16] Konno T (2001) Multistep nucleus formation and a separate subunit 
contribution of the amyloidgenesis of heat-denatured monellin. Protein Sci 10, 2093 
2101. 
 
 
134 
 
 
 
 
 
Part C 
_____________ 
 
Recombinant Proteins 
Procedures 
 
 
 
 
135 
 
 
Fig.1 RNase A and RNase A-Onc aminoacidic sequences 
C.1 Expression and purification of recombinant RNase A-
Onc 
Here is reported the effective expression of recombinant onconase in Escherichia 
coli inclusion bodies, the refolding of the protein, followed by its purification in high 
yields. 
 
Preparation of the mutant RNase A-Onc: design 
RNase A and Onconase share high sequence identity. The C-terminal hinge loop of 
Onconase was used as template to design the new mutant RNase A-Onc. As 
highlighted in Fig.1, the residues GNPYV corresponding to the sequence 112-116 of 
RNase A have been substituted with the residues NQA. 
 
 
RNase A 
KETAAAKFERQHMDSSTSAASSSNYCNQMMKSRNLTKDRCKP 
VNTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDC 
RETGSSKYPNCAYKTTQANKHIIVACEGNPYVPVHFDASV 
 
RNase A-Onc 
KETAAAKFERQHMDSSTSAASSSNYCNQMMKSRNLTKDRCKP 
VNTFVHESLADVQAVCSQKNVACKNGQTNCYQSYSTMSITDC 
RETGSSKYPNCAYKTTQANKHIIVACENQAPVHFDASV 
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The corresponding cDNA sequence was obtained from the aminoacid one 
CATATG AAA GAA ACA GCT GCA GCG AAA TTT GAG CGT CAA CAC 
ATG GAC AGT AGC ACT TCT GCA GCC TCA TCC AGC AAC TAT TGC AAC 
CAG ATG ATG AAA TCA CGC AAT CTG ACC AAA GAT CGC TGT AAA 
CCG GTG AAC ACG TTT GTG CAT GAA TCG TTA GCG GAT GTT CAG GCC 
GTA TGC TCT CAG AAG AAC GTT GCG TGC AAG AAT GGC CAG ACC 
AAC TGC TAT CAG AGC TAT TCC ACC ATG TCG ATT ACG GAC TGT CGT 
GAA ACC GGT AGT AGC AAA TAC CCG AAT TGT GCG TAC AAA ACG 
ACT CAA GCC AAC AAA CAC ATC ATT GTC GCG TGT GAG AAT CAA 
GCT CCA GTC CAT TTC GAT GCA TCG GTG TGA GGTACC GGATCC 
At the 5’ of the nucleotide sequence was added the CATATG restriction site for Nde 
I; the enzymatic cutting between A and T produces a fragment with the start-codon 
ATG in frame for the N-terminal Methyonine synthesis. At the 3’ of the cDNA 3 
sequences were included: a) the stop-codon TGA; b) the GGTACC restriction site 
for Kpn I to screen the positive clones after ligase reaction into the expression vector; 
c) the GGATCC restriction site for BamHI. The two restriction sites GGTACC and 
GGATCC,  were added after the stop-codon TGA. 
 
Preparation of the mutant RNase A-Onc: cloning 
procedures 
The cDNA encoding the mutant designed was purchased from GENEWIZ,Inc 
cloned into a pUC57-KAN commercial vector between BamHI and NdeI restriction 
sites (Fig.2). The vector pUC57-KAN was linearized with NdeI and BamHI to isolate 
the cDNA encoding RNase A-Onc (Fig.3). The expected fragment was isolated after 
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agarose-gel extraction and inserted with T4 ligase reaction into the expression vector 
pET22b+ between the NdeI/BamHI restriction sites (Fig.4). The resulting vector was 
used to transform TOP10 E.coli cells to follow the subsequent screening procedures. 
The transformed cells were growth on LB-agar plates containing 100 µg of AMP; 
five well-shaped cell colonies were picked and inoculated in LB medium containing 
100 µg of AMP. After the overnight growth at 37 °C, the cells were harvested and 
the plasmidic DNA was extracted by miniprep procedures. The integrity and the 
purity of the plasmidic DNA was checked by agarose gel electrophoresis. Each DNA 
sample was digested with KpnI to screen the effective internalization of the sequence 
encoding the RNase A-Onc mutant (Fig. 5). The KpnI+ clone, was selected and used 
to follow the expression procedures. 
 
 
Fig. 2 RNase A-Onc pUC57-Kan vector map 
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Fig. 3 Agarose gel electrophoresis. UC: uncut plasmid 
 
 
 
Fig. 4 pET22b+RNaseA-Onc vector map 
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Fig. 5 Agarose gel electrophoresis. KpnI enzymatic restriction screening 
 
Recombinant expression of RNaseA-Onc 
The plasmid obtained was transferred in BL21(DE3) cells strain of E.coli. The 
transformed cells were grown in LB medium at 37° C on analytical scale (5 mL) 
until reaching the final OD600 nm of 0.6 when the protein expression was induced 
adding 100 mM IPTG. After 3 hours from the induction, 1 mL of cultured cells was 
harvested while the remaining culture was keep at 37 °C for a comparative overnight 
induction. The corresponding pellets were treated with SDS-lysis buffer and boiled 
to extract the proteins. A little amount of sample corresponding to 5 µg of total 
proteins was loaded on SDS-poliacrilamide gel to check the RNaseA-Onc expression 
(Fig.6).  
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Fig. 6 SDS-PAGE. RNase A-Onc effective expression. 1: Marker; 2: No induction; 3: Induction fro 
3 hours; 4: Overnight induction; 5: RNase A wild type 
 
As showed in Fig. 6 (lane 3), an effective protein expression was reached after 3 
hours of induction while increasing the incubation time for the night does not 
significantly increase the RNaseA-Onc expression but only endogenous proteins 
were over-expressed.  
For preparative purposes, the transformed cells were inoculate in 1L fresh LB/AMP 
medium and grown until reaching the final OD600 nm of 0.6 when the protein 
expression was induced adding 0.4 mM IPTG. After 3 hours of induction, the cell 
were divided into 4 aliquots and harvested for centrifugation at 6000 rpm at 4 °C for 
30’.  
 
Isolation and denaturation of inclusion bodies 
 
Each aliquot was suspended in 20 ml of cold 0.10 M Tris-acetate pH 8.4 containing 
5 mM EDTA. The cell lysis was performed by sonication at 15 W for 20’ (30’’ on-
30’’off cycle) using a  Microson Ultrasonic Homogenizer XL2000. The engineered 
RNase-Onc was accumulated into the inclusion bodies so, after lysis, the cytosolic 
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fraction and the insoluble fraction were separated by centrifugation at 17500 RCF 
for 1 hour at 4 °C. The resulting pellets, containing the inclusion bodies, were treated 
with 15 ml of a detergent and denaturing solution of 0.10 M Tris-acetate, pH 8.4 
containing 2% Triton X100, 2M Urea,10 mM EDTA and sonicated for 20’. After 
that the samples were centrifuged for 30’ at 4 °C at 12500 RCF. After another 
sonication and centrifugation step, the pellet was washed in 15 ml of 0.10 M Tris-
acetate pH 8.4 containing 10 mM EDTA to remove Triton and urea.  Finally, the 
pellet corresponding to inclusion bodies mainly containing the recombinant 
RNaseA-Onc, was washed in 0.10 mM Tris-acetate pH 8.4.  All the washing 
procedures are checked on SDS-PAGE. Inclusion bodies were then dissolved in 15 
ml of 0.10 M Tris-acetate pH 8.4 containing 10 mM EDTA, 6 M Gdn-HCl and 25 
mM DTT, purged with N2, and incubated at 37 °C for 3 hours. The protein solution 
was dialyzed overnight versus 20 mM acetic acid at 4 °C to remove denaturants and 
reducing agents. Any insoluble material was removed by centrifugation in order to 
obtain a supernatant fraction containing the RNaseA-Onc in the completely reduced 
and denatured form. 
 
Renaturation procedures 
Renaturation of the derivatized protein was achieved by diluting samples in 100 mM 
Tris-acetate pH 8.4 at a final protein concentration of 0.1 mg ×mL-1 followed by 
addition of a redox mixture containing 3 mM glutathione-reduced and 0.6 mM 
glutathione-oxyded purged with N2. Maximal renaturation was obtained after 20 
hours at 25 °C. The renaturation reaction was stopped removing the redox 
glutathione by ultrafiltration on AMICON YM3 membrane (3000 Da exclusion cut-
off). By ultrafiltration, the sample containing RNase A-Onc was also equilibrated in 
20 mM acetic acid solution to change the pH from alkaline to acidic to inhibit the 
reoxidation reaction. 
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Purification of RNase A-Onc monomeric form 
The last step in the RNase A-Onc production, was represented by a gel filtration 
chromatography. The protein solution obtained from AMICON ultrafiltration, was 
loaded on a Sephadex G75 (1.5×72 cm) column previously equilibrated in 0.10 M 
ammonium acetate buffer pH 5.1. The monomeric RNase A-Onc was successfully 
purified from high molecular weight contaminants, as shown in Fig.7. The purity 
was also assessed by SDS-PAGE 15% and native PAGE 12% as reported in Fig. 8. 
The final yeld of pure monomeric RNaseA-Onc obtained by the corresponded to 13 
mg per liter of cultured cells in LB medium. 
 
 
Fig. 3 G75 pattern. RNase A-Onc isolated as monomeric form (M) 
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Fig. 4 Gel electrophoresis. A: SDS- PAGE 15%. B: native PAGE 12%. 1: RNase A wild type; 2: 
RNase A-Onc 
 
 
 
C.2 Expression and purification of recombinant MNEI 
 
 
 
Expression procedures 
 
The recombinant protein MNEI was expressed using a protocol set up in my 
laboratory. Cells of Escherichia coli BL21 (DE3) were transformed with plasmid 
pET22b+ carrying the gene encoding for MNEI. Cells were cultured on LB/Agar 
with ampicillin 100 mg×L-1 and they were grown over night at 37 °C. Subsequently, 
the cells were grown in LB medium containing the same antibiotic, at 37 °C with 
stir. Protein expression was induced at 0.8 OD/mL by supplying lactose 5 mM and 
carried on at 25 °C for 20 hours. The cells were harvested by centrifugation (4 °C, 
A B 
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4000 x g, 20 min), washed with cold PBS 1x (NaCl 7.6 g/L, Na2HPO4 1.875 
g/L, NaH2PO4 0.41 g/L) and stored frozen until protein extraction. 
 
 
Purification procedures 
 
To extract the protein, cells were re-suspended in cold sodium acetate 50 mM at pH 
5.5 and lysed by sonication on ice with a Microson Ultrasonic Homogenizer XL2000 
for 20’ (30’’ on-30’’ off). The protein-containing supernatant was recovered by 
centrifugation (4 °C, 7500 x g, 25 min). Purification was achieved by a one-step Ion-
Exchange Chromatography procedure: the cell lysate was applied to an anionic 
exchanger DEAE-Sepharose column (20 mL, GE Lifesciences) connected in series 
to a Macro-Prep High S cationic exchanger column (15 mL, Bio-Rad). The 
chromatography was monitored by UV absorbance at 280 nm. After loading the 
supernatant and washing the columns until to absorbance baseline, the recombinant 
protein was eluted from the Macro-Prep High S with NaCl 100 mM in sodium acetate 
50 mM, pH 5.5. The protein containing fractions were pooled, desalted by Size 
Exclusion Chromatography on a Sephadex G-25 column (GE Lifesciences) and 
eluted with acetic acid 100 mM. The fractions containing the desalted protein were 
put togheter and subjected to freeze-drying. Purity was assessed by Coomassie 
stained SDS-PAG. Protein yield was estimated by UV absorbance at 280 nm using 
the  (0.1%) of 1.41 and corresponds to 50 mg per liter of cultured cells in LB 
medium. 
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Final remarks 
The two proteins selected as natural and artificial models are very useful systems for 
aggregation studies. Thanks to their wide aggregation propensity, they allowed to 
investigate the influence of chemical, genetic and physical agents. 
RNase A is presented as a  model to study the metalation of proteins. The interaction 
between RNase A and Pt drugs improves protein oligomerization. Pt oligomers are 
endowed with peculiar characteristics such us SDS resistance and prolonged stability 
in solution. These results might suggest alternative aggregation mechanisms 
different from the well-known domain swapping. Pt-drugs selected also affect the 
biological action of RNase A evaluated both as enzymatic activity in a standard assay 
and also as cytotoxicity on tumoral cells.This suggest that the Pt-drugs deeply 
influence the structure and the function pf the protein as explained by solving the 
crystallographic structure of the cisplatinated monomer and of the carboplatinated 
monomer adducts. Further investigation on dimers may allow obtain structural 
information on Pt-dependent dimerization. 
RNase A is also presented as a helpful model to design new mutant with different 
structural features. The structural characterization of the mutant RNase A-Onc 
showed that shortening of the C-terminal hinge loop does not affect the global 
folding but can improve the aggregation propensity that, in this protein occurs 
spontaneously. Very likely, in this case 3D-DS is involved. Biophysical studies on 
dimers obtained in native conditions allow to characterise them and to compare their 
structures with the well-known swapped dimers. 
In this thesis, the artificial model MNEI was also presented as a suitable system. It 
represents a very fascinating model to study the influence of several physicochemical 
factors. It has been proven that pH, temperature and ionic strength deeply influence 
MNEI solubility and the aggregation towards amyloid-like patterns. The aggregation 
mechanism is worth of investigation whit the aim to obtain ordered assemblies under 
controlled conditions or avoid their formation and preserve the native structural and 
functional elements. 
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